Financial Metrics
EW Edwards Lifesciences CorpFinancial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 697300000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 759300000.0 | +8.9% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 739400000.0 | -2.6% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 883500000.0 | +19.5% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 841800000.0 | -4.7% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 821500000.0 | -2.4% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 894800000.0 | +8.9% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 943700000.0 | +5.5% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 906600000.0 | -3.9% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 993000000.0 | +9.5% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 1086900000.0 | +9.5% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 1094000000.0 | +0.7% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 1128700000.0 | +3.2% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 925000000.0 | -18.0% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 1140900000.0 | +23.3% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 1216600000.0 | +6.6% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 1376000000.0 | +13.1% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 1310200000.0 | -4.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1341200000.0 | +2.4% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 1373900000.0 | +2.4% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 1319000000.0 | -4.0% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 1459600000.0 | +10.7% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 1295500000.0 | -11.2% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 1243400000.0 | -4.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1329900000.0 | +7.0% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 1369400000.0 | +3.0% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 1354400000.0 | -1.1% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 1412700000.0 | +4.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1532200000.0 | +8.5% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1553100000.0 | +1.4% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2963700000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 3435300000.0 | +15.9% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 3722800000.0 | +8.4% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 4348000000.0 | +16.8% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 4386300000.0 | +0.9% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 5232500000.0 | +19.3% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 4464000000.0 | -14.7% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 5010000000.0 | +12.2% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 5439500000.0 | +8.6% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 6067600000.0 | +11.5% | USD | 10-K | 2026-02-25 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 517000000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 556800000.0 | +7.7% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 538000000.0 | -3.4% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 667900000.0 | +24.1% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 630700000.0 | -5.6% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 608200000.0 | -3.6% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 661200000.0 | +8.7% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 697500000.0 | +5.5% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 681700000.0 | -2.3% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 761200000.0 | +11.7% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 782900000.0 | +2.9% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 801600000.0 | +2.4% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 863600000.0 | +7.7% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 686800000.0 | -20.5% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 859900000.0 | +25.2% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 923200000.0 | +7.4% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 1041700000.0 | +12.8% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 998500000.0 | -4.1% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1041900000.0 | +4.3% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 1104500000.0 | +6.0% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 1065200000.0 | -3.6% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 1130100000.0 | +6.1% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 1038600000.0 | -8.1% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 992800000.0 | -4.4% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1043000000.0 | +5.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 1093900000.0 | +4.9% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 1091500000.0 | -0.2% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 1111100000.0 | +1.8% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1187800000.0 | +6.9% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1207900000.0 | +1.7% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2166300000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 2560000000.0 | +18.2% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 2783400000.0 | +8.7% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 3233600000.0 | +16.2% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 3305700000.0 | +2.2% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 3983600000.0 | +20.5% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 3740300000.0 | -6.1% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 4031600000.0 | +7.8% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 4322000000.0 | +7.2% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 4733400000.0 | +9.5% | USD | 10-K | 2026-02-25 |
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | 298300000.0 | — | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 241000000.0 | -19.2% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 214000000.0 | -11.2% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 252500000.0 | +18.0% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 252100000.0 | -0.2% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 248900000.0 | -1.3% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 274200000.0 | +10.2% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 267500000.0 | -2.4% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 294300000.0 | +10.0% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 358100000.0 | +21.7% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -169700000.0 | -147.4% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 357800000.0 | +310.8% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 383500000.0 | +7.2% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 542100000.0 | +41.4% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 390300000.0 | -28.0% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 438800000.0 | +12.4% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 459500000.0 | +4.7% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 402400000.0 | -12.4% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 388400000.0 | -3.5% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 263500000.0 | -32.2% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 365900000.0 | +38.9% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 349000000.0 | -4.6% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 366500000.0 | +5.0% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 350600000.0 | -4.3% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 394800000.0 | +12.6% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 411200000.0 | +4.2% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 307100000.0 | -25.3% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 751200000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 1089400000.0 | +45.0% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 748200000.0 | -31.3% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1146800000.0 | +53.3% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 897600000.0 | -21.7% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 1690300000.0 | +88.3% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 1498400000.0 | -11.4% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 1308900000.0 | -12.6% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 1378700000.0 | +5.3% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1264200000.0 | -8.3% | USD | 10-K | 2026-02-25 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2022-03-31 | 373600000.0 | — | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-06-30 | 406400000.0 | +8.8% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-09-30 | 343500000.0 | -15.5% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 340500000.0 | -0.9% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-06-30 | 305500000.0 | -10.3% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-09-30 | 383700000.0 | +25.6% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 351000000.0 | -8.5% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-06-30 | 365000000.0 | +4.0% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-09-30 | 3069400000.0 | +740.9% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 356400000.0 | -88.4% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-06-30 | 331500000.0 | -7.0% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-09-30 | 290300000.0 | -12.4% | USD | 10-Q | 2025-11-05 |
| Annual | 2021-12-31 | 1503100000.0 | — | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 1521900000.0 | +1.3% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 1399400000.0 | -8.0% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 4169700000.0 | +198.0% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1069400000.0 | -74.4% | USD | 10-K | 2026-02-25 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.67 | — | USD/shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.6 | -10.4% | USD/shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.66 | +10.0% | USD/shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 1.09 | +65.2% | USD/shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.88 | -19.3% | USD/shares | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 0.81 | -8.0% | USD/shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.98 | +21.0% | USD/shares | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 1.35 | +37.8% | USD/shares | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 1.08 | -20.0% | USD/shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 1.2 | +11.1% | USD/shares | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 0.39 | -67.5% | USD/shares | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 0.44 | +12.8% | USD/shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.5 | +13.6% | USD/shares | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -0.2 | -140.0% | USD/shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.52 | +360.0% | USD/shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 0.54 | +3.8% | USD/shares | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 0.79 | +46.3% | USD/shares | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 0.55 | -30.4% | USD/shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.6 | +9.1% | USD/shares | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 0.65 | +8.3% | USD/shares | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 0.55 | -15.4% | USD/shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.56 | +1.8% | USD/shares | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 0.51 | -8.9% | USD/shares | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 0.63 | +23.5% | USD/shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.58 | -7.9% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.61 | +5.2% | USD/shares | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 5.14 | +742.6% | USD/shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.61 | -88.1% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.57 | -6.6% | USD/shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.5 | -12.3% | USD/shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2.67 | — | USD/shares | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 2.77 | +3.7% | USD/shares | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 1.15 | -58.5% | USD/shares | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1.68 | +46.1% | USD/shares | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 1.32 | -21.4% | USD/shares | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 2.41 | +82.6% | USD/shares | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 2.46 | +2.1% | USD/shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 2.31 | -6.1% | USD/shares | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 6.98 | +202.2% | USD/shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1.84 | -73.6% | USD/shares | 10-K | 2026-02-25 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.66 | — | USD/shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.58 | -12.1% | USD/shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.65 | +12.1% | USD/shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 1.06 | +63.1% | USD/shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.86 | -18.9% | USD/shares | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 0.79 | -8.1% | USD/shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.96 | +21.5% | USD/shares | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 1.32 | +37.5% | USD/shares | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 1.06 | -19.7% | USD/shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 1.18 | +11.3% | USD/shares | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 0.38 | -67.8% | USD/shares | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 0.43 | +13.2% | USD/shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.49 | +14.0% | USD/shares | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -0.2 | -140.8% | USD/shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.52 | +360.0% | USD/shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 0.54 | +3.8% | USD/shares | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 0.78 | +44.4% | USD/shares | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 0.54 | -30.8% | USD/shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.59 | +9.3% | USD/shares | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 0.65 | +10.2% | USD/shares | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 0.55 | -15.4% | USD/shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.56 | +1.8% | USD/shares | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 0.5 | -10.7% | USD/shares | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 0.63 | +26.0% | USD/shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.58 | -7.9% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.61 | +5.2% | USD/shares | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 5.13 | +741.0% | USD/shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.61 | -88.1% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.56 | -8.2% | USD/shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.5 | -10.7% | USD/shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2.61 | — | USD/shares | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 2.7 | +3.4% | USD/shares | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 1.13 | -58.1% | USD/shares | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1.64 | +45.1% | USD/shares | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 1.3 | -20.7% | USD/shares | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 2.38 | +83.1% | USD/shares | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 2.44 | +2.5% | USD/shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 2.3 | -5.7% | USD/shares | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 6.97 | +203.0% | USD/shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1.83 | -73.7% | USD/shares | 10-K | 2026-02-25 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 501400000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 369900000.0 | -26.2% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 645000000.0 | +74.4% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2016-12-31 | 930100000.0 | +44.2% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2017-03-31 | 819300000.0 | -11.9% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 508200000.0 | -38.0% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 630300000.0 | +24.0% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2017-12-31 | 818300000.0 | +29.8% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 1227000000.0 | +49.9% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 1226400000.0 | -0.0% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 1261300000.0 | +2.8% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 714100000.0 | -43.4% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 709200000.0 | -0.7% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 726800000.0 | +2.5% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 1186600000.0 | +63.3% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 1179100000.0 | -0.6% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 662900000.0 | -43.8% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 903500000.0 | +36.3% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 1024000000.0 | +13.3% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 1183200000.0 | +15.5% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 1174200000.0 | -0.8% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 1312800000.0 | +11.8% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 1506900000.0 | +14.8% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 862800000.0 | -42.7% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1030900000.0 | +19.5% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 1198100000.0 | +16.2% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 1247800000.0 | +4.1% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 769000000.0 | -38.4% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 872500000.0 | +13.5% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 1042600000.0 | +19.5% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 1410100000.0 | +35.2% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 1132300000.0 | -19.7% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1224600000.0 | +8.2% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 1644500000.0 | +34.3% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 3676400000.0 | +123.6% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 3045200000.0 | -17.2% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 3140600000.0 | +3.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 3272800000.0 | +4.2% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 2685600000.0 | -17.9% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 930100000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 818300000.0 | -12.0% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 714100000.0 | -12.7% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1179100000.0 | +65.1% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 1183200000.0 | +0.3% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 862800000.0 | -27.1% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 769000000.0 | -10.9% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 1132300000.0 | +47.2% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 3045200000.0 | +168.9% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 2938000000.0 | -3.5% | USD | 10-K | 2026-02-25 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-12-31 | 438700000.0 | — | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 406600000.0 | -7.3% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 431400000.0 | +6.1% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 423800000.0 | -1.8% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2019-12-31 | 543600000.0 | +28.3% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-09-30 | 549700000.0 | +1.1% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 514600000.0 | -6.4% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 586600000.0 | +14.0% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 640500000.0 | +9.2% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 600600000.0 | -6.2% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 582200000.0 | -3.1% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 636300000.0 | +9.3% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 636400000.0 | +0.0% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 618100000.0 | -2.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 643000000.0 | +4.0% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 717700000.0 | +11.6% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 754400000.0 | +5.1% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 739800000.0 | -1.9% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 771500000.0 | +4.3% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 817600000.0 | +6.0% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 778300000.0 | -4.8% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 716000000.0 | -8.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 609100000.0 | -14.9% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 669200000.0 | +9.9% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 697000000.0 | +4.2% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 693300000.0 | -0.5% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 365500000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 438700000.0 | +20.0% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 456900000.0 | +4.1% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 543600000.0 | +19.0% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 514600000.0 | -5.3% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 582200000.0 | +13.1% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 643000000.0 | +10.4% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 771500000.0 | +20.0% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 609100000.0 | -21.0% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 659600000.0 | +8.3% | USD | 10-K | 2026-02-25 |
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 356600000.0 | — | USD | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 367600000.0 | +3.1% | USD | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 401000000.0 | +9.1% | USD | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 396600000.0 | -1.1% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 431400000.0 | +8.8% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 491600000.0 | +14.0% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 538400000.0 | +9.5% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 554900000.0 | +3.1% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 573900000.0 | +3.4% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 568100000.0 | -1.0% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 583800000.0 | +2.8% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 607000000.0 | +4.0% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 630900000.0 | +3.9% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 624900000.0 | -1.0% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 611100000.0 | -2.2% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 640900000.0 | +4.9% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 662200000.0 | +3.3% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 735100000.0 | +11.0% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 773300000.0 | +5.2% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 802300000.0 | +3.8% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 767900000.0 | -4.3% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 759500000.0 | -1.1% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 737800000.0 | -2.9% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 726700000.0 | -1.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 730600000.0 | +0.5% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 740000000.0 | +1.3% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 757800000.0 | +2.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 875500000.0 | +15.5% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 914300000.0 | +4.4% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 980200000.0 | +7.2% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 1032400000.0 | +5.3% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 903500000.0 | -12.5% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1207300000.0 | +33.6% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 1024700000.0 | -15.1% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 1104200000.0 | +7.8% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 1086700000.0 | -1.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 1113900000.0 | +2.5% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1141700000.0 | +2.5% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1140900000.0 | -0.1% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 396600000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 554900000.0 | +39.9% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 607000000.0 | +9.4% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 640900000.0 | +5.6% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 802300000.0 | +25.2% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 726700000.0 | -9.4% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 875500000.0 | +20.5% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 903500000.0 | +3.2% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 1086700000.0 | +20.3% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1126200000.0 | +3.6% | USD | 10-K | 2026-02-25 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1819300000.0 | — | USD | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 1985100000.0 | +9.1% | USD | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 2171400000.0 | +9.4% | USD | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 2240000000.0 | +3.2% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 2018400000.0 | -9.9% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 2283400000.0 | +13.1% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 2566400000.0 | +12.4% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 2549200000.0 | -0.7% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 2716900000.0 | +6.6% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 2696000000.0 | -0.8% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 2912600000.0 | +8.0% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 2286900000.0 | -21.5% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 2368800000.0 | +3.6% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 2354700000.0 | -0.6% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 2739700000.0 | +16.4% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 2984000000.0 | +8.9% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 2507900000.0 | -16.0% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 2690300000.0 | +7.3% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 2980400000.0 | +10.8% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 3091000000.0 | +3.7% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 3069200000.0 | -0.7% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 3322900000.0 | +8.3% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 3515500000.0 | +5.8% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 3180700000.0 | -9.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 3241300000.0 | +1.9% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 3263100000.0 | +0.7% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 3513900000.0 | +7.7% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 3095800000.0 | -11.9% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 3257200000.0 | +5.2% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 3647000000.0 | +12.0% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 4067500000.0 | +11.5% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 4035700000.0 | -0.8% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 4170500000.0 | +3.3% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 4516000000.0 | +8.3% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 6727700000.0 | +49.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 6285400000.0 | -6.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 6212700000.0 | -1.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 6577200000.0 | +5.9% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 6358900000.0 | -3.3% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2240000000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 2549200000.0 | +13.8% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 2286900000.0 | -10.3% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 2984000000.0 | +30.5% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 3091000000.0 | +3.6% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 3180700000.0 | +2.9% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 3095800000.0 | -2.7% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 4035700000.0 | +30.4% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 6285400000.0 | +55.7% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 6738900000.0 | +7.2% | USD | 10-K | 2026-02-25 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3853800000.0 | — | USD | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 4051400000.0 | +5.1% | USD | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 4339000000.0 | +7.1% | USD | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 4510000000.0 | +3.9% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 4780400000.0 | +6.0% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 5138500000.0 | +7.5% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 5488400000.0 | +6.8% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 5666400000.0 | +3.2% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 5825100000.0 | +2.8% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 5686100000.0 | -2.4% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 5958200000.0 | +4.8% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 5323700000.0 | -10.6% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 5469300000.0 | +2.7% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 5573500000.0 | +1.9% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 5966300000.0 | +7.0% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 6488100000.0 | +8.7% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 6076100000.0 | -6.4% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 6424100000.0 | +5.7% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 6800800000.0 | +5.9% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 7237100000.0 | +6.4% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 7213700000.0 | -0.3% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 7662100000.0 | +6.2% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 8160300000.0 | +6.5% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 8502600000.0 | +4.2% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 8419900000.0 | -1.0% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 8425100000.0 | +0.1% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 8638200000.0 | +2.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 8292500000.0 | -4.0% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 8651200000.0 | +4.3% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 9004000000.0 | +4.1% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 9370800000.0 | +4.1% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 9363200000.0 | -0.1% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 9736300000.0 | +4.0% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 10099300000.0 | +3.7% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 12971200000.0 | +28.4% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 13055300000.0 | +0.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 13022300000.0 | -0.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 13488700000.0 | +3.6% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 13272200000.0 | -1.6% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 4510000000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 5666400000.0 | +25.6% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 5323700000.0 | -6.0% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 6488100000.0 | +21.9% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 7237100000.0 | +11.5% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 8502600000.0 | +17.5% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 8292500000.0 | -2.5% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 9363200000.0 | +12.9% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 13055300000.0 | +39.4% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 13697200000.0 | +4.9% | USD | 10-K | 2026-02-25 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-12-31 | 532500000.0 | — | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-09-30 | 735200000.0 | +38.1% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 1420000000.0 | +93.1% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 1314500000.0 | -7.4% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 1183200000.0 | -10.0% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 1261100000.0 | +6.6% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 876600000.0 | -30.5% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 646500000.0 | -26.2% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 697000000.0 | +7.8% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 775800000.0 | +11.3% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 902400000.0 | +16.3% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 746900000.0 | -17.2% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 873200000.0 | +16.9% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 846300000.0 | -3.1% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 893900000.0 | +5.6% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 799000000.0 | -10.6% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 886200000.0 | +10.9% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 966500000.0 | +9.1% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 1032300000.0 | +6.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 949900000.0 | -8.0% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 969100000.0 | +2.0% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 917900000.0 | -5.3% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 1022400000.0 | +11.4% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 1082000000.0 | +5.8% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 1157200000.0 | +7.0% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 1238900000.0 | +7.1% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 1195400000.0 | -3.5% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1110800000.0 | -7.1% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 1217000000.0 | +9.6% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 1944100000.0 | +59.7% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 1505200000.0 | -22.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 1394800000.0 | -7.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1404700000.0 | +0.7% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1588000000.0 | +13.0% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 532500000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 1420000000.0 | +166.7% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 876600000.0 | -38.3% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 902400000.0 | +2.9% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 893900000.0 | -0.9% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 1032300000.0 | +15.5% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 1022400000.0 | -1.0% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 1195400000.0 | +16.9% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 1505200000.0 | +25.9% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1813700000.0 | +20.5% | USD | 10-K | 2026-02-25 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2020-12-31 | 2662800000.0 | — | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-09-30 | 2619000000.0 | -1.6% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 2666700000.0 | +1.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 2575000000.0 | -3.4% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 2481500000.0 | -3.6% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 2420400000.0 | -2.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 2485800000.0 | +2.7% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 2589200000.0 | +4.2% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 2557500000.0 | -1.2% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 2643700000.0 | +3.4% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 2643800000.0 | +0.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 2549900000.0 | -3.6% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 2594700000.0 | +1.8% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 3359800000.0 | +29.5% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 2992400000.0 | -10.9% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 2830700000.0 | -5.4% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 2882200000.0 | +1.8% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 3067200000.0 | +6.4% | USD | 10-Q | 2025-11-05 |
| Annual | 2020-12-31 | 2662800000.0 | — | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 2666700000.0 | +0.1% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 2485800000.0 | -6.8% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 2643800000.0 | +6.4% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 2992400000.0 | +13.2% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 3359600000.0 | +12.3% | USD | 10-K | 2026-02-25 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2299300000.0 | — | USD | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 2471200000.0 | +7.5% | USD | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 2691800000.0 | +8.9% | USD | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 2619000000.0 | -2.7% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 2742700000.0 | +4.7% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 2939600000.0 | +7.2% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 3162500000.0 | +7.6% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 2956200000.0 | -6.5% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2018-03-31 | 3245700000.0 | +9.8% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2018-06-30 | 3164200000.0 | -2.5% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2018-09-30 | 3361300000.0 | +6.2% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2018-12-31 | 3140400000.0 | -6.6% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2019-03-31 | 3447500000.0 | +9.8% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2019-06-30 | 3500300000.0 | +1.5% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2019-09-30 | 3814800000.0 | +9.0% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2019-12-31 | 4148300000.0 | +8.7% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2020-03-31 | 3901100000.0 | -6.0% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2020-06-30 | 3839100000.0 | -1.6% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2020-09-30 | 4210300000.0 | +9.7% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2020-12-31 | 4574300000.0 | +8.6% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-03-31 | 4658400000.0 | +1.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-06-30 | 5133300000.0 | +10.2% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-09-30 | 5541300000.0 | +7.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-12-31 | 5835900000.0 | +5.3% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-03-31 | 5844900000.0 | +0.2% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-06-30 | 5943600000.0 | +1.7% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-09-30 | 6217800000.0 | +4.6% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2022-12-31 | 5806700000.0 | -6.6% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-03-31 | 6062000000.0 | +4.4% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-06-30 | 6446500000.0 | +6.3% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-09-30 | 6727100000.0 | +4.4% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2023-12-31 | 6719400000.0 | -0.1% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-03-31 | 7186400000.0 | +7.0% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-06-30 | 7504600000.0 | +4.4% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-09-30 | 9611400000.0 | +28.1% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2024-12-31 | 10062900000.0 | +4.7% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 10191600000.0 | +1.3% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-06-30 | 10606500000.0 | +4.1% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-09-30 | 10205000000.0 | -3.8% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 2619000000.0 | — | USD | 10-K | 2020-02-14 |
| Annual | 2017-12-31 | 2956200000.0 | +12.9% | USD | 10-K | 2021-02-12 |
| Annual | 2018-12-31 | 3140400000.0 | +6.2% | USD | 10-K | 2022-02-14 |
| Annual | 2019-12-31 | 4148300000.0 | +32.1% | USD | 10-K | 2023-02-13 |
| Annual | 2020-12-31 | 4574300000.0 | +10.3% | USD | 10-K | 2024-02-12 |
| Annual | 2021-12-31 | 5835900000.0 | +27.6% | USD | 10-K | 2025-02-28 |
| Annual | 2022-12-31 | 5806700000.0 | -0.5% | USD | 10-K | 2026-02-25 |
| Annual | 2023-12-31 | 6719400000.0 | +15.7% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 10062900000.0 | +49.8% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 10337600000.0 | +2.7% | USD | 10-K | 2026-02-25 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 602200000.0 | — | USD | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 602500000.0 | +0.0% | USD | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 600600000.0 | -0.3% | USD | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 822300000.0 | +36.9% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 847900000.0 | +3.1% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 1016800000.0 | +19.9% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 1034000000.0 | +1.7% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 438400000.0 | -57.6% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 456000000.0 | +4.0% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 593900000.0 | +30.2% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 593600000.0 | -0.1% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 593800000.0 | +0.0% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 593900000.0 | +0.0% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 594100000.0 | +0.0% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 594200000.0 | +0.0% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 594400000.0 | +0.0% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 594600000.0 | +0.0% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 594700000.0 | +0.0% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 594900000.0 | +0.0% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 595000000.0 | +0.0% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 595200000.0 | +0.0% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 595400000.0 | +0.0% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 595500000.0 | +0.0% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 595700000.0 | +0.0% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 595900000.0 | +0.0% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 596000000.0 | +0.0% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 596200000.0 | +0.0% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 596300000.0 | +0.0% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 596500000.0 | +0.0% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 596700000.0 | +0.0% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 596800000.0 | +0.0% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 597000000.0 | +0.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 597200000.0 | +0.0% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 597300000.0 | +0.0% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 597500000.0 | +0.0% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 597700000.0 | +0.0% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 597800000.0 | +0.0% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 598000000.0 | +0.0% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 598200000.0 | +0.0% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 822300000.0 | — | USD | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 438400000.0 | -46.7% | USD | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 593800000.0 | +35.4% | USD | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 594400000.0 | +0.1% | USD | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 595000000.0 | +0.1% | USD | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 595700000.0 | +0.1% | USD | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 596300000.0 | +0.1% | USD | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 597000000.0 | +0.1% | USD | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 597700000.0 | +0.1% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 598300000.0 | +0.1% | USD | 10-K | 2026-02-25 |
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | 128300000.0 | — | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 326000000.0 | +154.1% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 636800000.0 | +95.3% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 151300000.0 | -76.2% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 291500000.0 | +92.7% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 633800000.0 | +117.4% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 1500000.0 | -99.8% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 342700000.0 | +22746.7% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 780000000.0 | +127.6% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 207100000.0 | -73.4% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 438400000.0 | +111.7% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 654500000.0 | +49.3% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 300500000.0 | -54.1% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 826600000.0 | +175.1% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 1358500000.0 | +64.3% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 293300000.0 | -78.4% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 625500000.0 | +113.3% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 935400000.0 | +49.5% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 314100000.0 | -66.4% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 347700000.0 | +10.7% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 759200000.0 | +118.3% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | -53500000.0 | -107.0% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 318000000.0 | +694.4% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 669800000.0 | +110.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 280400000.0 | -58.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 570600000.0 | +103.5% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1144300000.0 | +100.5% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 704400000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 1000700000.0 | +42.1% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 926700000.0 | -7.4% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1182900000.0 | +27.6% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 1054300000.0 | -10.9% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 1732100000.0 | +64.3% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 1218200000.0 | -29.7% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 895800000.0 | -26.5% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 542300000.0 | -39.5% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1595200000.0 | +194.2% | USD | 10-K | 2026-02-25 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | 151200000.0 | — | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | -487000000.0 | -422.1% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | -696500000.0 | -43.0% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 220300000.0 | +131.6% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 325200000.0 | +47.6% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 71000000.0 | -78.2% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | -49500000.0 | -169.7% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | -137800000.0 | -178.4% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | -150500000.0 | -9.2% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | -134700000.0 | +10.5% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -144900000.0 | -7.6% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | -271200000.0 | -87.2% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | -49700000.0 | +81.7% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | -379200000.0 | -663.0% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | -756600000.0 | -99.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 229500000.0 | +130.3% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 359100000.0 | +56.5% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 157600000.0 | -56.1% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 500000.0 | -99.7% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 70700000.0 | +14040.0% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 159700000.0 | +125.9% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 63100000.0 | -60.5% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 187900000.0 | +197.8% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 2889600000.0 | +1437.8% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 85300000.0 | -97.0% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | -86800000.0 | -201.8% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | -514600000.0 | -492.9% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | -211700000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | -647200000.0 | -205.7% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 76700000.0 | +111.9% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | -595800000.0 | -876.8% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | -531100000.0 | +10.9% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | -1722500000.0 | -224.3% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 252300000.0 | +114.6% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 173800000.0 | -31.1% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 2312900000.0 | +1230.8% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -712900000.0 | -130.8% | USD | 10-K | 2026-02-25 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | -391300000.0 | — | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | -264500000.0 | +32.4% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | -244200000.0 | +7.7% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 40900000.0 | +116.7% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | -199800000.0 | -588.5% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | -256500000.0 | -28.4% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 44400000.0 | +117.3% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | -187000000.0 | -521.2% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | -152600000.0 | +18.4% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | -586400000.0 | -284.3% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -562300000.0 | +4.1% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | -528300000.0 | +6.0% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | -274300000.0 | +48.1% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | -333300000.0 | -21.5% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | -294300000.0 | +11.7% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | -368100000.0 | -25.1% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | -676200000.0 | -83.7% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | -746100000.0 | -10.3% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | -206600000.0 | +72.3% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | -154500000.0 | +25.2% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | -297800000.0 | -92.8% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 61700000.0 | +120.7% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -34900000.0 | -156.6% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | -1011600000.0 | -2798.6% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | -258000000.0 | +74.5% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | -205300000.0 | +20.4% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | -945400000.0 | -360.5% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | -268500000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | -473200000.0 | -76.2% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | -1101200000.0 | -132.7% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | -115600000.0 | +89.5% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | -486900000.0 | -321.2% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | -356300000.0 | +26.8% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | -1584500000.0 | -344.7% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | -711000000.0 | +55.1% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | -983000000.0 | -38.3% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -956800000.0 | +2.7% | USD | 10-K | 2026-02-25 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 27700000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 64800000.0 | +133.9% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 112900000.0 | +74.2% | USD | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 15900000.0 | -85.9% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 73900000.0 | +364.8% | USD | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 116200000.0 | +57.2% | USD | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 43200000.0 | -62.8% | USD | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 96000000.0 | +122.2% | USD | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 181100000.0 | +88.6% | USD | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 42200000.0 | -76.7% | USD | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 106800000.0 | +153.1% | USD | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 182900000.0 | +71.3% | USD | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 82200000.0 | -55.1% | USD | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 190500000.0 | +131.8% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 293800000.0 | +54.2% | USD | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 106000000.0 | -63.9% | USD | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 175300000.0 | +65.4% | USD | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 236000000.0 | +34.6% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 72700000.0 | -69.2% | USD | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 115800000.0 | +59.3% | USD | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 175700000.0 | +51.7% | USD | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 61500000.0 | -65.0% | USD | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 109400000.0 | +77.9% | USD | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 164700000.0 | +50.5% | USD | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 65300000.0 | -60.4% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 150700000.0 | +130.8% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 202600000.0 | +34.4% | USD | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 56000000.0 | -72.4% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 105300000.0 | +88.0% | USD | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 162800000.0 | +54.6% | USD | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 176100000.0 | — | USD | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 168100000.0 | -4.5% | USD | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 238700000.0 | +42.0% | USD | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 254400000.0 | +6.6% | USD | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 407000000.0 | +60.0% | USD | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 325800000.0 | -20.0% | USD | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 244600000.0 | -24.9% | USD | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 253000000.0 | +3.4% | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 252400000.0 | -0.2% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 260200000.0 | +3.1% | USD | 10-K | 2026-02-25 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 211900000.0 | — | shares | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 212700000.0 | +0.4% | shares | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 213700000.0 | +0.5% | shares | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 211600000.0 | -1.0% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 210400000.0 | -0.6% | shares | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 211100000.0 | +0.3% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 211600000.0 | +0.2% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 209700000.0 | -0.9% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 210700000.0 | +0.5% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 209200000.0 | -0.7% | shares | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 209100000.0 | -0.0% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 207700000.0 | -0.7% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 208400000.0 | +0.3% | shares | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 207900000.0 | -0.2% | shares | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 208500000.0 | +0.3% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 209100000.0 | +0.3% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 206500000.0 | -1.2% | shares | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 621400000.0 | +200.9% | shares | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 622900000.0 | +0.2% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 624300000.0 | +0.2% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 621800000.0 | -0.4% | shares | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 623100000.0 | +0.2% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 624200000.0 | +0.2% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 624100000.0 | -0.0% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 621400000.0 | -0.4% | shares | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 619800000.0 | -0.3% | shares | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 619400000.0 | -0.1% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 608300000.0 | -1.8% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 606000000.0 | -0.4% | shares | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 607900000.0 | +0.3% | shares | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 606500000.0 | -0.2% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 601100000.0 | -0.9% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 602400000.0 | +0.2% | shares | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 602300000.0 | -0.0% | shares | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 589800000.0 | -2.1% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 588600000.0 | -0.2% | shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 586200000.0 | -0.4% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 587900000.0 | +0.3% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 580700000.0 | -1.2% | shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 211600000.0 | — | shares | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 209700000.0 | -0.9% | shares | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 207700000.0 | -1.0% | shares | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 209100000.0 | +0.7% | shares | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 624300000.0 | +198.6% | shares | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 624100000.0 | -0.0% | shares | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 608300000.0 | -2.5% | shares | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 601100000.0 | -1.2% | shares | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 588600000.0 | -2.1% | shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 580700000.0 | -1.3% | shares | 10-K | 2026-02-25 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 239800000.0 | — | shares | 10-Q | 2016-04-29 |
| Quarterly | 2016-06-30 | 241000000.0 | +0.5% | shares | 10-Q | 2016-07-29 |
| Quarterly | 2016-09-30 | 242000000.0 | +0.4% | shares | 10-Q | 2016-10-28 |
| Quarterly | 2016-12-31 | 242600000.0 | +0.2% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 243200000.0 | +0.2% | shares | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 244700000.0 | +0.6% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 211600000.0 | -13.5% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 212000000.0 | +0.2% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 213000000.0 | +0.5% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 214000000.0 | +0.5% | shares | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 214800000.0 | +0.4% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 215200000.0 | +0.2% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 216000000.0 | +0.4% | shares | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 216900000.0 | +0.4% | shares | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 217500000.0 | +0.3% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 218100000.0 | +0.3% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 218500000.0 | +0.2% | shares | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 633500000.0 | +189.9% | shares | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 635000000.0 | +0.2% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 636400000.0 | +0.2% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 637500000.0 | +0.2% | shares | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 640100000.0 | +0.4% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 641200000.0 | +0.2% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 642000000.0 | +0.1% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 642900000.0 | +0.1% | shares | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 645000000.0 | +0.3% | shares | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 645700000.0 | +0.1% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 646300000.0 | +0.1% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 647100000.0 | +0.1% | shares | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 649100000.0 | +0.3% | shares | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 649900000.0 | +0.1% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 650500000.0 | +0.1% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 651800000.0 | +0.2% | shares | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 653500000.0 | +0.3% | shares | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 654300000.0 | +0.1% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 654800000.0 | +0.1% | shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 655900000.0 | +0.2% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 657600000.0 | +0.3% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 658200000.0 | +0.1% | shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 242600000.0 | — | shares | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 212000000.0 | -12.6% | shares | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 215200000.0 | +1.5% | shares | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 218100000.0 | +1.3% | shares | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 636400000.0 | +191.8% | shares | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 642000000.0 | +0.9% | shares | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 646300000.0 | +0.7% | shares | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 650500000.0 | +0.6% | shares | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 654800000.0 | +0.7% | shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 658700000.0 | +0.6% | shares | 10-K | 2026-02-25 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 213100000.0 | — | shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 212200000.0 | -0.4% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 213200000.0 | +0.5% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 211200000.0 | -0.9% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 210500000.0 | -0.3% | shares | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 211300000.0 | +0.4% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 210200000.0 | -0.5% | shares | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 209500000.0 | -0.3% | shares | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 209000000.0 | -0.2% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 207900000.0 | -0.5% | shares | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 624400000.0 | +200.3% | shares | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 624600000.0 | +0.0% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 624600000.0 | +0.0% | shares | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 620300000.0 | -0.7% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 622100000.0 | +0.3% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 623200000.0 | +0.2% | shares | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 622300000.0 | -0.1% | shares | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 623600000.0 | +0.2% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 622100000.0 | -0.2% | shares | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 620900000.0 | -0.2% | shares | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 619800000.0 | -0.2% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 607500000.0 | -2.0% | shares | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 606900000.0 | -0.1% | shares | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 607000000.0 | +0.0% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 601600000.0 | -0.9% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 602100000.0 | +0.1% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 597200000.0 | -0.8% | shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 586900000.0 | -1.7% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 587000000.0 | +0.0% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 584700000.0 | -0.4% | shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 213000000.0 | — | shares | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 210900000.0 | -1.0% | shares | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 627600000.0 | +197.6% | shares | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 624800000.0 | -0.4% | shares | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 622600000.0 | -0.4% | shares | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 623300000.0 | +0.1% | shares | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 619000000.0 | -0.7% | shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 606700000.0 | -2.0% | shares | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 597700000.0 | -1.5% | shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 584800000.0 | -2.2% | shares | 10-K | 2026-02-25 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 217800000.0 | — | shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 217300000.0 | -0.2% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 218100000.0 | +0.4% | shares | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 216400000.0 | -0.8% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 215700000.0 | -0.3% | shares | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 216200000.0 | +0.2% | shares | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 215100000.0 | -0.5% | shares | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 214000000.0 | -0.5% | shares | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 213200000.0 | -0.4% | shares | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 212200000.0 | -0.5% | shares | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 636200000.0 | +199.8% | shares | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 636300000.0 | +0.0% | shares | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 635100000.0 | -0.2% | shares | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 620300000.0 | -2.3% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 631000000.0 | +1.7% | shares | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 631300000.0 | +0.0% | shares | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 629900000.0 | -0.2% | shares | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 631700000.0 | +0.3% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 629400000.0 | -0.4% | shares | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 626700000.0 | -0.4% | shares | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 624500000.0 | -0.4% | shares | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 610900000.0 | -2.2% | shares | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 610300000.0 | -0.1% | shares | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 609500000.0 | -0.1% | shares | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 604100000.0 | -0.9% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 604300000.0 | +0.0% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 598100000.0 | -1.0% | shares | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 587800000.0 | -1.7% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 587900000.0 | +0.0% | shares | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 585700000.0 | -0.4% | shares | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 217800000.0 | — | shares | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 215900000.0 | -0.9% | shares | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 640900000.0 | +196.9% | shares | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 636700000.0 | -0.7% | shares | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 631900000.0 | -0.8% | shares | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 631200000.0 | -0.1% | shares | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 624200000.0 | -1.1% | shares | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 609400000.0 | -2.4% | shares | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 599300000.0 | -1.7% | shares | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 585800000.0 | -2.3% | shares | 10-K | 2026-02-25 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 9Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1809 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.1874 | +3.6% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.1704 | -9.1% | ratio | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 0.1848 | +8.5% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.1638 | -11.4% | ratio | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 0.1497 | -8.6% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.1536 | +2.6% | ratio | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 0.1660 | +8.0% | ratio | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 0.1522 | -8.3% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 0.1816 | +19.3% | ratio | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 0.1950 | +7.4% | ratio | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 0.1834 | -6.0% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.1858 | +1.3% | ratio | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 0.1440 | -22.5% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.1678 | +16.5% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 0.1687 | +0.5% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 0.1796 | +6.5% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 0.1606 | -10.6% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.1593 | -0.8% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 0.1631 | +2.4% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 0.1527 | -6.4% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.1687 | +10.5% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 0.1439 | -14.7% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 0.1327 | -7.8% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.1366 | +2.9% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.1356 | -0.7% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 0.1044 | -23.0% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.1085 | +3.9% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.1136 | +4.7% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.1170 | +3.0% | ratio | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 0.6571 | — | ratio | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 0.6063 | -7.7% | ratio | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 0.6993 | +15.3% | ratio | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 0.6701 | -4.2% | ratio | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 0.6061 | -9.6% | ratio | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 0.6154 | +1.5% | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.5383 | -12.5% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.5351 | -0.6% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.4167 | -22.1% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.4430 | +6.3% | ratio | 10-K | 2026-02-25 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-12-31 | 4.2066 | — | ratio | 10-Q | 2017-10-27 |
| Quarterly | 2017-09-30 | 3.4908 | -17.0% | ratio | 10-Q | 2017-10-27 |
| Quarterly | 2017-12-31 | 1.7952 | -48.6% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 2.0669 | +15.1% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 2.2786 | +10.2% | ratio | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 2.3096 | +1.4% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 2.6088 | +13.0% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 3.6640 | +40.4% | ratio | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 3.3783 | -7.8% | ratio | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 3.5315 | +4.5% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 3.3067 | -6.4% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 3.3577 | +1.5% | ratio | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 3.0810 | -8.2% | ratio | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 3.5217 | +14.3% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 3.4579 | -1.8% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 3.8413 | +11.1% | ratio | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 3.7496 | -2.4% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 3.6374 | -3.0% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 3.0812 | -15.3% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 3.4123 | +10.7% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 3.3671 | -1.3% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 3.8282 | +13.7% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 3.0280 | -20.9% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 3.0104 | -0.6% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 3.1516 | +4.7% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 3.2832 | +4.2% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 3.3760 | +2.8% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 3.7545 | +11.2% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 3.7108 | -1.2% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 3.4606 | -6.7% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 4.1758 | +20.7% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 4.4542 | +6.7% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 4.6823 | +5.1% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 4.0043 | -14.5% | ratio | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 4.2066 | — | ratio | 10-K | 2018-02-16 |
| Annual | 2017-12-31 | 1.7952 | -57.3% | ratio | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 2.6088 | +45.3% | ratio | 10-K | 2020-02-14 |
| Annual | 2019-12-31 | 3.3067 | +26.8% | ratio | 10-K | 2021-02-12 |
| Annual | 2020-12-31 | 3.4579 | +4.6% | ratio | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 3.0812 | -10.9% | ratio | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 3.0280 | -1.7% | ratio | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 3.3760 | +11.5% | ratio | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 4.1758 | +23.7% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 3.7156 | -11.0% | ratio | 10-K | 2026-02-25 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2020-12-31 | 0.5821 | — | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-09-30 | 0.4726 | -18.8% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 0.4569 | -3.3% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.4406 | -3.6% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 0.4175 | -5.2% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 0.3893 | -6.8% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 0.4281 | +10.0% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.4271 | -0.2% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 0.3967 | -7.1% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 0.3930 | -0.9% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 0.3935 | +0.1% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.3548 | -9.8% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 0.3457 | -2.6% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 0.3496 | +1.1% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 0.2974 | -14.9% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.2777 | -6.6% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.2717 | -2.2% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.3006 | +10.6% | ratio | 10-Q | 2025-11-05 |
| Annual | 2020-12-31 | 0.5821 | — | ratio | 10-K | 2022-02-14 |
| Annual | 2021-12-31 | 0.4569 | -21.5% | ratio | 10-K | 2023-02-13 |
| Annual | 2022-12-31 | 0.4281 | -6.3% | ratio | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 0.3935 | -8.1% | ratio | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 0.2974 | -24.4% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.3250 | +9.3% | ratio | 10-K | 2026-02-25 |
Gross Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.7414 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.7333 | -1.1% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.7276 | -0.8% | ratio | 10-Q | 2017-10-27 |
| Quarterly | 2017-03-31 | 0.7560 | +3.9% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.7492 | -0.9% | ratio | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 0.7404 | -1.2% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.7389 | -0.2% | ratio | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 0.7391 | +0.0% | ratio | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 0.7519 | +1.7% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 0.7666 | +1.9% | ratio | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 0.7203 | -6.0% | ratio | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 0.7327 | +1.7% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.7651 | +4.4% | ratio | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | 0.7425 | -3.0% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.7537 | +1.5% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 0.7588 | +0.7% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 0.7570 | -0.2% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 0.7621 | +0.7% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.7768 | +1.9% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 0.8039 | +3.5% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 0.8076 | +0.5% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.7743 | -4.1% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 0.8017 | +3.5% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 0.7985 | -0.4% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.7843 | -1.8% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.7988 | +1.9% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 0.8059 | +0.9% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.7865 | -2.4% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.7752 | -1.4% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.7777 | +0.3% | ratio | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 0.7309 | — | ratio | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 0.7452 | +2.0% | ratio | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 0.7477 | +0.3% | ratio | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 0.7437 | -0.5% | ratio | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 0.7536 | +1.3% | ratio | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 0.7613 | +1.0% | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.8379 | +10.1% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.8047 | -4.0% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.7946 | -1.3% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.7801 | -1.8% | ratio | 10-K | 2026-02-25 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2022-03-31 | 0.2786 | — | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-06-30 | 0.2958 | +6.2% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-09-30 | 0.2604 | -12.0% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.2333 | -10.4% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-06-30 | 0.2358 | +1.1% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-09-30 | 0.3086 | +30.9% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.2639 | -14.5% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-06-30 | 0.2665 | +1.0% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-09-30 | 2.2662 | +750.2% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.2523 | -88.9% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-06-30 | 0.2164 | -14.2% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-09-30 | 0.1869 | -13.6% | ratio | 10-Q | 2025-11-05 |
| Annual | 2021-12-31 | 0.2873 | — | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.3409 | +18.7% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.2793 | -18.1% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.7666 | +174.4% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.1762 | -77.0% | ratio | 10-K | 2026-02-25 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | 0.3376 | — | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.2863 | -15.2% | ratio | 10-Q | 2018-07-27 |
| Quarterly | 2017-09-30 | 0.2605 | -9.0% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.2822 | +8.3% | ratio | 10-Q | 2019-04-26 |
| Quarterly | 2018-06-30 | 0.2671 | -5.3% | ratio | 10-Q | 2019-07-26 |
| Quarterly | 2018-09-30 | 0.2745 | +2.8% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 0.2761 | +0.6% | ratio | 10-Q | 2020-04-28 |
| Quarterly | 2019-06-30 | 0.2461 | -10.9% | ratio | 10-Q | 2020-07-27 |
| Quarterly | 2019-09-30 | 0.2690 | +9.3% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.3173 | +17.9% | ratio | 10-Q | 2021-04-28 |
| Quarterly | 2020-06-30 | -0.1835 | -157.8% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.3136 | +270.9% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 0.3152 | +0.5% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2021-06-30 | 0.3940 | +25.0% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2021-09-30 | 0.2979 | -24.4% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.3272 | +9.8% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2022-06-30 | 0.3344 | +2.2% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2022-09-30 | 0.3051 | -8.8% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.2661 | -12.8% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2023-06-30 | 0.2034 | -23.6% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2023-09-30 | 0.2943 | +44.7% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.2624 | -10.8% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.2676 | +2.0% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2024-09-30 | 0.2589 | -3.3% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.2795 | +8.0% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.2684 | -4.0% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 0.1977 | -26.3% | ratio | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 0.2535 | — | ratio | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 0.3171 | +25.1% | ratio | 10-K | 2020-02-14 |
| Annual | 2018-12-31 | 0.2010 | -36.6% | ratio | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 0.2638 | +31.2% | ratio | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 0.2046 | -22.4% | ratio | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 0.3230 | +57.9% | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.3357 | +3.9% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.2613 | -22.2% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.2535 | -3.0% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.2084 | -17.8% | ratio | 10-K | 2026-02-25 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-12-31 | 1.7467 | — | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2017-09-30 | 0.8573 | -50.9% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2017-12-31 | 0.5763 | -32.8% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-03-31 | 0.9334 | +62.0% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 1.0365 | +11.0% | ratio | 10-Q | 2018-07-27 |
| Quarterly | 2018-09-30 | 1.0002 | -3.5% | ratio | 10-Q | 2018-10-26 |
| Quarterly | 2018-12-31 | 0.8146 | -18.6% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-03-31 | 1.0970 | +34.7% | ratio | 10-Q | 2019-04-26 |
| Quarterly | 2019-06-30 | 1.0428 | -4.9% | ratio | 10-Q | 2019-07-26 |
| Quarterly | 2019-09-30 | 1.5295 | +46.7% | ratio | 10-Q | 2019-10-25 |
| Quarterly | 2019-12-31 | 1.3066 | -14.6% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-03-31 | 0.8875 | -32.1% | ratio | 10-Q | 2020-04-28 |
| Quarterly | 2020-06-30 | 1.0347 | +16.6% | ratio | 10-Q | 2020-07-27 |
| Quarterly | 2020-09-30 | 1.2100 | +16.9% | ratio | 10-Q | 2020-10-26 |
| Quarterly | 2020-12-31 | 1.3236 | +9.4% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-03-31 | 1.4696 | +11.0% | ratio | 10-Q | 2021-04-28 |
| Quarterly | 2021-06-30 | 1.4814 | +0.8% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 1.5591 | +5.2% | ratio | 10-Q | 2021-10-29 |
| Quarterly | 2021-12-31 | 0.8358 | -46.4% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1.0853 | +29.8% | ratio | 10-Q | 2022-04-28 |
| Quarterly | 2022-06-30 | 1.2363 | +13.9% | ratio | 10-Q | 2022-07-29 |
| Quarterly | 2022-09-30 | 1.3594 | +10.0% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 0.7522 | -44.7% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.8064 | +7.2% | ratio | 10-Q | 2023-04-28 |
| Quarterly | 2023-06-30 | 0.9010 | +11.7% | ratio | 10-Q | 2023-07-28 |
| Quarterly | 2023-09-30 | 1.1382 | +26.3% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-12-31 | 0.9472 | -16.8% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 1.1024 | +16.4% | ratio | 10-Q | 2024-04-29 |
| Quarterly | 2024-06-30 | 1.3513 | +22.6% | ratio | 10-Q | 2024-07-31 |
| Quarterly | 2024-09-30 | 1.8911 | +39.9% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-12-31 | 2.0231 | +7.0% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 2.2516 | +11.3% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 2.3299 | +3.5% | ratio | 10-Q | 2025-08-06 |
| Quarterly | 2025-09-30 | 1.6912 | -27.4% | ratio | 10-Q | 2025-11-05 |
| Annual | 2016-12-31 | 1.7467 | — | ratio | 10-K | 2019-02-15 |
| Annual | 2017-12-31 | 0.5763 | -67.0% | ratio | 10-K | 2019-02-15 |
| Annual | 2018-12-31 | 0.8146 | +41.4% | ratio | 10-K | 2021-02-12 |
| Annual | 2019-12-31 | 1.3066 | +60.4% | ratio | 10-K | 2022-02-14 |
| Annual | 2020-12-31 | 1.3236 | +1.3% | ratio | 10-K | 2023-02-13 |
| Annual | 2021-12-31 | 0.8358 | -36.9% | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.7522 | -10.0% | ratio | 10-K | 2024-02-12 |
| Annual | 2023-12-31 | 0.9472 | +25.9% | ratio | 10-K | 2025-02-28 |
| Annual | 2024-12-31 | 2.0231 | +113.6% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1.6199 | -19.9% | ratio | 10-K | 2026-02-25 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2022-03-31 | 0.0444 | — | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-06-30 | 0.0482 | +8.7% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-09-30 | 0.0398 | -17.6% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.0394 | -1.0% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-06-30 | 0.0339 | -13.8% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-09-30 | 0.0409 | +20.7% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.0361 | -12.0% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-06-30 | 0.0361 | +0.3% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-09-30 | 0.2366 | +554.7% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.0274 | -88.4% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-06-30 | 0.0246 | -10.2% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-09-30 | 0.0219 | -11.0% | ratio | 10-Q | 2025-11-05 |
| Annual | 2021-12-31 | 0.1768 | — | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.1835 | +3.8% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.1495 | -18.6% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.3194 | +113.7% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.0781 | -75.6% | ratio | 10-K | 2026-02-25 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2022-03-31 | 0.0639 | — | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-06-30 | 0.0684 | +7.0% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2022-09-30 | 0.0552 | -19.2% | ratio | 10-Q | 2023-10-27 |
| Quarterly | 2023-03-31 | 0.0562 | +1.7% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-06-30 | 0.0474 | -15.6% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2023-09-30 | 0.0570 | +20.4% | ratio | 10-Q | 2024-11-06 |
| Quarterly | 2024-03-31 | 0.0488 | -14.4% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-06-30 | 0.0486 | -0.4% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2024-09-30 | 0.3193 | +556.6% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-03-31 | 0.0350 | -89.0% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-06-30 | 0.0313 | -10.6% | ratio | 10-Q | 2025-11-05 |
| Quarterly | 2025-09-30 | 0.0284 | -9.0% | ratio | 10-Q | 2025-11-05 |
| Annual | 2021-12-31 | 0.2576 | — | ratio | 10-K | 2024-02-12 |
| Annual | 2022-12-31 | 0.2621 | +1.8% | ratio | 10-K | 2025-02-28 |
| Annual | 2023-12-31 | 0.2083 | -20.5% | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.4144 | +99.0% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.1034 | -75.0% | ratio | 10-K | 2026-02-25 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-04-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,000 | $0.00 | $0 | 13,000 |
| 2026-04-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 8,324 | $79.79 | $664,144 | 39,699 |
| 2026-04-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 4,676 | $80.50 | $376,401 | 48,023 |
| 2026-04-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 13,000 | $59.26 | $770,337 | 52,699 |
| 2026-04-06 | Lippis Daniel J. | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 1,019 | $0.00 | $0 | 2,038 |
| 2026-04-06 | Lippis Daniel J. | CVP, TAVR |
Open-market sell
S
|
Common Stock | 1,019 | $80.98 | $82,523 | 33,934 |
| 2026-04-06 | Lippis Daniel J. | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 1,019 | $59.26 | $60,383 | 34,953 |
| 2026-04-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 22,680 | $0.00 | $0 | 0 |
| 2026-04-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 18,004 | $80.05 | $1,441,209 | 21,266 |
| 2026-04-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,676 | $80.59 | $376,846 | 39,270 |
| 2026-04-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 22,680 | $59.26 | $1,343,942 | 43,946 |
| 2026-03-11 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,000 | $0.00 | $0 | 26,000 |
| 2026-03-11 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,901 | $85.21 | $673,228 | 39,699 |
| 2026-03-11 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 5,099 | $84.46 | $430,668 | 47,600 |
| 2026-03-11 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 13,000 | $59.26 | $770,337 | 52,699 |
| 2026-03-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,340 | $0.00 | $0 | 22,680 |
| 2026-03-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 11,340 | $85.93 | $974,430 | 21,266 |
| 2026-03-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,340 | $59.26 | $671,971 | 32,606 |
| 2026-02-25 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 24,000 | $83.84 | $2,012,076 | 21,266 |
| 2026-02-22 | Lippis Daniel J. | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 432 | $79.78 | $34,465 | 33,934 |
| 2026-02-17 | Lippis Daniel J. | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 198 | $75.87 | $15,022 | 34,366 |
| 2026-02-16 | Lippis Daniel J. | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 258 | $75.87 | $19,574 | 34,564 |
| 2026-02-16 | Ullem Scott B. | CVP, Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 199 | $75.87 | $15,098 | 39,699 |
| 2026-02-12 | Lippis Daniel J. | CVP, TAVR |
Equity grant / award
A
|
Common Stock | 12,820 | $0.00 | $0 | 34,822 |
| 2026-01-09 | Lippis Daniel J. | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 1,019 | $0.00 | $0 | 4,076 |
| 2026-01-09 | Lippis Daniel J. | CVP, TAVR |
Open-market sell
S
|
Common Stock | 1,019 | $85.70 | $87,332 | 22,002 |
| 2026-01-09 | Lippis Daniel J. | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 1,019 | $59.26 | $60,383 | 23,021 |
| 2026-01-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,340 | $0.00 | $0 | 34,020 |
| 2026-01-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 8,708 | $85.98 | $748,708 | 31,870 |
| 2026-01-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 2,632 | $84.62 | $222,721 | 40,578 |
| 2026-01-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,340 | $59.26 | $671,971 | 43,210 |
| 2025-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 7,100 | $0.00 | $0 | 31,870 |
| 2025-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,900 | $83.74 | $494,066 | 38,970 |
| 2025-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,486 | $83.79 | $459,682 | 44,870 |
| 2025-12-11 | Chopra Daveen | CVP, TMTT & Surgical |
Open-market sell
S
|
Common Stock | 2,000 | $84.38 | $168,750 | 32,201 |
| 2025-12-10 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 3,863 | $83.45 | $322,367 | 8,597 |
| 2025-12-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,340 | $0.00 | $0 | 45,360 |
| 2025-12-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 11,340 | $83.83 | $950,581 | 50,356 |
| 2025-12-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,340 | $59.26 | $671,971 | 61,696 |
| 2025-12-09 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 3,863 | $0.00 | $0 | 12,460 |
| 2025-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,700 | $0.00 | $0 | 39,000 |
| 2025-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,700 | $84.47 | $650,412 | 39,898 |
| 2025-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,700 | $59.26 | $456,277 | 47,598 |
| 2025-12-08 | Zovighian Bernard J | CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 25,350 | $0.00 | $0 | 25,350 |
| 2025-12-08 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 21,487 | $85.21 | $1,831,006 | 84,839 |
| 2025-12-08 | Zovighian Bernard J | CEO |
Exercise / conversion
M
|
Common Stock | 25,350 | $59.26 | $1,502,157 | 106,326 |
| 2025-11-13 | Dahl Andrew M. | SVP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 1,160 | $0.00 | $0 | 9,183 |
| 2025-11-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,000 | $0.00 | $0 | 46,700 |
| 2025-11-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 10,026 | $83.02 | $832,360 | 39,898 |
| 2025-11-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 2,974 | $83.30 | $247,734 | 49,924 |
| 2025-11-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 13,000 | $59.26 | $770,337 | 52,898 |
| 2025-09-13 | Dahl Andrew M. | SVP, Corporate Controller |
Other disposed transaction
F
|
Common Stock | 262 | $77.57 | $20,323 | 7,927 |
| 2025-09-11 | Chopra Daveen | CVP, TMTT & Surgical |
Equity grant / award
A
|
Common Stock | 3,205 | $0.00 | $0 | 34,201 |
| 2025-08-25 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 2,500 | $81.95 | $204,865 | 30,996 |
| 2025-08-18 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,950 | $0.00 | $0 | 35,800 |
| 2025-08-18 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 8,950 | $78.06 | $698,679 | 206,900 |
| 2025-08-18 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M
|
Common Stock | 8,950 | $59.26 | $530,347 | 215,850 |
| 2025-07-28 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 4,114 | $79.46 | $326,900 | 22,002 |
| 2025-07-11 | Bruls Annette | CVP, EMEACLA |
Other disposed transaction
F
|
Common Stock | 109 | $78.80 | $8,589 | 14,171 |
| 2025-07-07 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 333 | $76.79 | $25,571 | 26,116 |
| 2025-06-16 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,950 | $0.00 | $0 | 44,750 |
| 2025-06-16 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 8,950 | $75.23 | $673,268 | 206,900 |
| 2025-06-16 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M
|
Common Stock | 8,950 | $59.26 | $530,347 | 215,850 |
| 2025-06-03 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 967 | $77.32 | $74,772 | 8,597 |
| 2025-06-02 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 2,570 | $77.40 | $198,911 | 50,356 |
| 2025-05-30 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 16,099 | $77.21 | $1,243,065 | 9,564 |
| 2025-05-22 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 1,500 | $75.08 | $112,612 | 33,496 |
| 2025-05-16 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 5,816 | $0.00 | $0 | 25,663 |
| 2025-05-13 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 2,771 | $0.00 | $0 | 19,847 |
| 2025-05-11 | Zovighian Bernard J | CEO |
Other disposed transaction
F
|
Common Stock | 2,860 | $73.68 | $210,725 | 89,563 |
| 2025-05-09 | VALERIANI NICHOLAS J | Dir |
Equity grant / award
A
|
Common Stock | 5,564 | $0.00 | $0 | 79,296 |
| 2025-05-08 | Markowitz Wayne | GM & SVP, Surgical |
Equity grant / award
A · derivative
|
Performance Rights | 3,350 | $0.00 | $0 | 3,350 |
| 2025-05-08 | Markowitz Wayne | GM & SVP, Surgical |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 17,100 | $0.00 | $0 | 17,100 |
| 2025-05-08 | Markowitz Wayne | GM & SVP, Surgical |
Equity grant / award
A
|
Common Stock | 3,350 | $0.00 | $0 | 12,349 |
| 2025-05-08 | Bruls Annette | CVP, EMEACLA |
Equity grant / award
A · derivative
|
Performance Rights | 6,200 | $0.00 | $0 | 6,200 |
| 2025-05-08 | Bruls Annette | CVP, EMEACLA |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 31,600 | $0.00 | $0 | 31,600 |
| 2025-05-08 | Bruls Annette | CVP, EMEACLA |
Equity grant / award
A
|
Common Stock | 6,200 | $0.00 | $0 | 14,280 |
| 2025-05-07 | Markowitz Wayne | GM & SVP, Surgical |
Other disposed transaction
F
|
Common Stock | 300 | $74.92 | $22,476 | 8,999 |
| 2025-05-07 | Markowitz Wayne | GM & SVP, Surgical |
Open-market sell
S
|
Common Stock | 268 | $75.08 | $20,121 | 9,299 |
| 2025-05-06 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 1,036 | $0.00 | $0 | 12,954 |
| 2025-05-05 | Zovighian Bernard J | CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,462 | $0.00 | $0 | 0 |
| 2025-05-05 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 5,980 | $74.91 | $447,977 | 58,284 |
| 2025-05-05 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 1,482 | $0.00 | $0 | 11,918 |
| 2025-05-05 | Zovighian Bernard J | CEO |
Exercise / conversion
M
|
Common Stock | 7,462 | $45.28 | $337,855 | 65,746 |
| 2025-05-04 | Zovighian Bernard J | CEO |
Other disposed transaction
F
|
Common Stock | 543 | $75.65 | $41,078 | 58,284 |
| 2025-05-03 | Zovighian Bernard J | CEO |
Other disposed transaction
F
|
Common Stock | 527 | $75.65 | $39,868 | 58,827 |
| 2025-04-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 9,500 | $0.00 | $0 | 0 |
| 2025-04-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 9,500 | $69.81 | $663,196 | 47,206 |
| 2025-04-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 9,500 | $45.28 | $430,129 | 56,706 |
| 2025-04-08 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 300 | $0.00 | $0 | 330 |
| 2025-04-08 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 300 | $70.61 | $21,183 | 22,863 |
| 2025-04-08 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 300 | $45.28 | $13,583 | 23,163 |
| 2025-03-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,250 | $0.00 | $0 | 11,250 |
| 2025-03-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 11,250 | $70.87 | $797,267 | 30,387 |
| 2025-03-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 11,250 | $45.28 | $509,363 | 41,637 |
| 2025-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 9,500 | $0.00 | $0 | 9,500 |
| 2025-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 9,500 | $67.96 | $645,624 | 46,936 |
| 2025-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 9,500 | $45.28 | $430,129 | 56,436 |
| 2025-03-10 | Zovighian Bernard J | CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,463 | $0.00 | $0 | 7,462 |
| 2025-03-10 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 6,164 | $69.51 | $428,448 | 59,083 |
| 2025-03-10 | Zovighian Bernard J | CEO |
Equity grant / award
G
|
Common Stock | 1,299 | $0.00 | $0 | 10,436 |
| 2025-03-10 | Zovighian Bernard J | CEO |
Exercise / conversion
M
|
Common Stock | 7,463 | $45.28 | $337,900 | 66,546 |
| 2025-02-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,250 | $0.00 | $0 | 22,500 |
| 2025-02-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,760 | $70.52 | $547,204 | 30,387 |
| 2025-02-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,490 | $71.38 | $249,123 | 38,147 |
| 2025-02-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 11,250 | $45.28 | $509,363 | 41,637 |
| 2025-02-22 | Dahl Andrew M. | SVP, Corporate Controller |
Other disposed transaction
F
|
Common Stock | 176 | $73.30 | $12,901 | 4,684 |
| 2025-02-18 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 222 | $76.19 | $16,914 | 22,588 |
| 2025-02-17 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 165 | $76.19 | $12,571 | 22,810 |
| 2025-02-16 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 214 | $76.19 | $16,305 | 22,975 |
| 2025-02-14 | LORANGER STEVEN R | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 5,739 | $0.00 | $0 | 0 |
| 2025-02-14 | LORANGER STEVEN R | Dir |
Open-market sell
S
|
Common Stock | 5,739 | $76.42 | $438,576 | 60,372 |
| 2025-02-14 | LORANGER STEVEN R | Dir |
Exercise / conversion
M
|
Common Stock | 5,739 | $45.32 | $260,073 | 66,111 |
| 2025-02-13 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,250 | $0.00 | $0 | 33,750 |
| 2025-02-13 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 11,250 | $75.76 | $852,272 | 30,561 |
| 2025-02-13 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 11,250 | $45.28 | $509,363 | 41,811 |
| 2025-01-16 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 500 | $0.00 | $0 | 1,530 |
| 2025-01-16 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 500 | $68.76 | $34,382 | 23,189 |
| 2025-01-16 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 500 | $45.28 | $22,638 | 23,689 |
| 2024-12-16 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $0.00 | $0 | 2,030 |
| 2024-12-16 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 2,500 | $74.08 | $185,196 | 23,189 |
| 2024-12-16 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 2,500 | $45.28 | $113,192 | 25,689 |
| 2024-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,250 | $0.00 | $0 | 45,000 |
| 2024-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 11,250 | $71.68 | $806,406 | 30,561 |
| 2024-12-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 11,250 | $45.28 | $509,363 | 41,811 |
| 2024-12-06 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 1,750 | $73.27 | $128,223 | 27,583 |
| 2024-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 35,500 |
| 2024-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $65.57 | $327,843 | 46,936 |
| 2024-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-11-05 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 25,000 | $65.91 | $1,647,862 | 198,526 |
| 2024-10-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 40,500 |
| 2024-10-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $69.51 | $347,534 | 46,936 |
| 2024-10-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-09-14 | Markowitz Wayne | GM & SVP, Surgical |
Other disposed transaction
F
|
Common Stock | 648 | $68.52 | $44,401 | 10,033 |
| 2024-09-13 | Dahl Andrew M. | SVP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 2,920 | $0.00 | $0 | 4,691 |
| 2024-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 45,500 |
| 2024-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $66.77 | $333,826 | 46,936 |
| 2024-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-09-03 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 5,530 | $69.96 | $386,879 | 81,287 |
| 2024-09-03 | Szyman Catherine M. | CVP, Critical Care |
Equity grant / award
A
|
Common Stock | 10,910 | $0.00 | $0 | 86,817 |
| 2024-08-20 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 1,250 | $69.95 | $87,438 | 29,333 |
| 2024-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 50,500 |
| 2024-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $66.08 | $330,420 | 46,936 |
| 2024-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-07-11 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 500 | $0.00 | $0 | 4,530 |
| 2024-07-11 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 500 | $94.18 | $47,090 | 23,189 |
| 2024-07-11 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 500 | $45.28 | $22,638 | 23,689 |
| 2024-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 55,500 |
| 2024-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $93.29 | $466,474 | 46,936 |
| 2024-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-07-07 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 258 | $92.32 | $23,819 | 75,907 |
| 2024-06-20 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 535 | $0.00 | $0 | 5,030 |
| 2024-06-20 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 535 | $90.00 | $48,150 | 23,513 |
| 2024-06-20 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 535 | $45.28 | $24,223 | 24,048 |
| 2024-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 60,500 |
| 2024-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $87.54 | $437,696 | 46,936 |
| 2024-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 51,936 |
| 2024-05-30 | Zovighian Bernard J | CEO |
Open-market sell
S
|
Common Stock | 8,617 | $87.68 | $755,539 | 68,218 |
| 2024-05-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,625 | $0.00 | $0 | 61,875 |
| 2024-05-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 5,625 | $90.45 | $508,803 | 30,561 |
| 2024-05-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 5,625 | $45.28 | $254,681 | 36,186 |
| 2024-05-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Other disposed transaction
F
|
Common Stock | 814 | $86.72 | $70,590 | 46,936 |
| 2024-05-11 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Other disposed transaction
F
|
Common Stock | 229 | $86.72 | $19,859 | 17,081 |
| 2024-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 65,500 |
| 2024-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,000 | $87.81 | $439,038 | 47,750 |
| 2024-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,000 | $45.28 | $226,384 | 52,750 |
| 2024-05-08 | LORANGER STEVEN R | Dir |
Equity grant / award
A
|
Common Stock | 999 | $0.00 | $0 | 60,372 |
| 2024-05-08 | LORANGER STEVEN R | Dir |
Equity grant / award
A
|
Common Stock | 3,055 | $0.00 | $0 | 59,373 |
| 2024-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
A · derivative
|
Performance Rights | 6,700 | $0.00 | $0 | 6,700 |
| 2024-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 39,600 | $0.00 | $0 | 39,600 |
| 2024-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Other disposed transaction
F
|
Common Stock | 619 | $85.09 | $52,671 | 47,750 |
| 2024-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
A
|
Common Stock | 6,700 | $0.00 | $0 | 48,369 |
| 2024-05-06 | Zovighian Bernard J | CEO |
Open-market buy
P
|
Common Stock | 580 | $85.74 | $49,753 | 3,268 |
| 2024-05-04 | Zovighian Bernard J | CEO |
Exercise / conversion
M · derivative
|
Performance Rights | 6,265 | $0.00 | $0 | 0 |
| 2024-05-04 | Zovighian Bernard J | CEO |
Other disposed transaction
F
|
Common Stock | 3,718 | $85.25 | $316,960 | 46,836 |
| 2024-05-04 | Zovighian Bernard J | CEO |
Exercise / conversion
M
|
Common Stock | 6,265 | $0.00 | $0 | 50,554 |
| 2024-05-03 | Zovighian Bernard J | CEO |
Other disposed transaction
F
|
Common Stock | 527 | $85.06 | $44,827 | 44,289 |
| 2024-05-02 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 0 |
| 2024-05-02 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 17,143 | $84.59 | $1,450,126 | 4,486 |
| 2024-05-02 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 12,207 | $85.02 | $1,037,839 | 21,629 |
| 2024-05-02 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2024-05-01 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 14,400 | $0.00 | $0 | 0 |
| 2024-05-01 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Open-market sell
S
|
Common Stock | 12,240 | $84.11 | $1,029,449 | 173,849 |
| 2024-05-01 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Open-market sell
S
|
Common Stock | 2,160 | $84.83 | $183,238 | 186,089 |
| 2024-05-01 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M
|
Common Stock | 14,400 | $36.75 | $529,200 | 188,249 |
| 2024-04-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,250 | $0.00 | $0 | 0 |
| 2024-04-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 6,550 | $85.74 | $561,579 | 19,074 |
| 2024-04-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 700 | $86.40 | $60,483 | 25,624 |
| 2024-04-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,250 | $36.75 | $266,438 | 26,324 |
| 2024-04-09 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 857 | $0.00 | $0 | 857 |
| 2024-04-09 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 857 | $92.34 | $79,135 | 17,488 |
| 2024-04-09 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 857 | $36.75 | $31,495 | 18,345 |
| 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 14,400 | $0.00 | $0 | 14,400 |
| 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA |
Open-market sell
S
|
Common Stock | 14,293 | $92.32 | $1,319,558 | 173,849 |
| 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA |
Open-market sell
S
|
Common Stock | 107 | $92.65 | $9,914 | 188,142 |
| 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA |
Exercise / conversion
M
|
Common Stock | 14,400 | $36.75 | $529,200 | 188,249 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 29,350 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 16,618 | $92.70 | $1,540,489 | 4,486 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 9,820 | $91.54 | $898,923 | 21,104 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 2,712 | $93.72 | $254,169 | 30,924 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 200 | $94.19 | $18,838 | 33,636 |
| 2024-04-04 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 7,250 |
| 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 6,387 | $94.81 | $605,521 | 19,074 |
| 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 868 | $95.51 | $82,903 | 25,461 |
| 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,329 |
| 2024-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 14,500 | $0.00 | $0 | 12,500 |
| 2024-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 14,500 | $91.01 | $1,319,696 | 39,503 |
| 2024-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 14,500 | $36.75 | $532,875 | 54,003 |
| 2024-03-11 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 14,400 | $0.00 | $0 | 28,800 |
| 2024-03-11 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Open-market sell
S
|
Common Stock | 14,400 | $91.68 | $1,320,149 | 173,584 |
| 2024-03-11 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M
|
Common Stock | 14,400 | $36.75 | $529,200 | 187,984 |
| 2024-03-07 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 1,715 | $0.00 | $0 | 1,714 |
| 2024-03-07 | Lippis Daniel J. | CVP, JAPAC |
Open-market sell
S
|
Common Stock | 1,715 | $90.98 | $156,031 | 17,213 |
| 2024-03-07 | Lippis Daniel J. | CVP, JAPAC |
Exercise / conversion
M
|
Common Stock | 1,715 | $36.75 | $63,026 | 18,928 |
| 2024-03-04 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 58,700 |
| 2024-03-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 16,040 | $87.05 | $1,396,282 | 4,486 |
| 2024-03-04 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 13,310 | $86.21 | $1,147,455 | 20,526 |
| 2024-03-04 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2024-02-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 14,505 |
| 2024-02-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,255 | $85.59 | $620,923 | 19,074 |
| 2024-02-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,329 |
| 2024-02-23 | GALLAHUE KIERAN | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 7,056 | $0.00 | $0 | 0 |
| 2024-02-23 | GALLAHUE KIERAN | Dir |
Open-market sell
S
|
Common Stock | 3,058 | $87.61 | $267,911 | 67,219 |
| 2024-02-23 | GALLAHUE KIERAN | Dir |
Equity grant / award
G
|
Common Stock | 7,056 | $0.00 | $0 | 70,277 |
| 2024-02-23 | GALLAHUE KIERAN | Dir |
Exercise / conversion
M
|
Common Stock | 7,056 | $36.86 | $260,107 | 10,757 |
| 2024-02-22 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 1,998 | $0.00 | $0 | 15,085 |
| 2024-02-21 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,000 | $0.00 | $0 | 0 |
| 2024-02-21 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 7,000 | $86.75 | $607,268 | 22,750 |
| 2024-02-21 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 1,200 | $86.67 | $104,004 | 29,750 |
| 2024-02-21 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 7,000 | $59.26 | $414,797 | 30,950 |
| 2024-02-18 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 188 | $86.10 | $16,187 | 17,213 |
| 2024-02-17 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 150 | $86.10 | $12,915 | 17,401 |
| 2024-02-16 | Lippis Daniel J. | CVP, JAPAC |
Other disposed transaction
F
|
Common Stock | 207 | $86.04 | $17,810 | 17,551 |
| 2024-02-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 27,000 | $0.00 | $0 | 0 |
| 2024-02-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 27,000 | $85.62 | $2,311,654 | 34,814 |
| 2024-02-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 27,000 | $36.75 | $992,250 | 61,814 |
| 2024-02-13 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 20,000 | $0.00 | $0 | 27,000 |
| 2024-02-13 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 20,000 | $86.46 | $1,729,200 | 34,814 |
| 2024-02-13 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 20,000 | $36.75 | $735,000 | 54,814 |
| 2024-02-12 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 12,210 | $0.00 | $0 | 0 |
| 2024-02-12 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Open-market sell
S
|
Common Stock | 12,210 | $87.00 | $1,062,270 | 13,087 |
| 2024-02-12 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 12,210 | $36.75 | $448,718 | 25,297 |
| 2024-02-08 | STONE HEISZ LESLIE | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 7,056 | $0.00 | $0 | 0 |
| 2024-02-08 | STONE HEISZ LESLIE | Dir |
Open-market sell
S
|
Common Stock | 7,056 | $86.45 | $609,991 | 26,980 |
| 2024-02-08 | STONE HEISZ LESLIE | Dir |
Exercise / conversion
M
|
Common Stock | 7,056 | $36.86 | $260,107 | 34,036 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 88,050 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 12,167 | $87.55 | $1,065,221 | 4,486 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 9,761 | $86.44 | $843,741 | 16,653 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 6,422 | $88.63 | $569,182 | 26,414 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $89.61 | $89,610 | 32,836 |
| 2024-02-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 21,760 |
| 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,255 | $78.29 | $567,994 | 19,248 |
| 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,503 |
| 2024-01-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,000 | $0.00 | $0 | 38,000 |
| 2024-01-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 10,000 | $75.67 | $756,700 | 39,503 |
| 2024-01-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 10,000 | $36.75 | $367,500 | 49,503 |
| 2024-01-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 117,400 |
| 2024-01-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 26,850 | $72.94 | $1,958,439 | 4,486 |
| 2024-01-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 2,500 | $73.46 | $183,650 | 31,336 |
| 2024-01-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 14,510 | $0.00 | $0 | 29,015 |
| 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 14,510 | $76.55 | $1,110,794 | 19,248 |
| 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 14,510 | $36.75 | $533,242 | 33,758 |
| 2023-12-15 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,000 | $0.00 | $0 | 7,000 |
| 2023-12-15 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 7,000 | $78.25 | $547,724 | 23,950 |
| 2023-12-15 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 7,000 | $59.26 | $414,797 | 30,950 |
| 2023-12-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,000 | $0.00 | $0 | 48,000 |
| 2023-12-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 8,000 | $71.86 | $574,880 | 39,503 |
| 2023-12-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 8,000 | $36.75 | $294,000 | 47,503 |
| 2023-12-06 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,500 | $0.00 | $0 | 14,000 |
| 2023-12-06 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 3,500 | $70.00 | $245,006 | 23,950 |
| 2023-12-06 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 3,500 | $59.26 | $207,398 | 27,450 |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,660 | $0.00 | $0 | 8,658 |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 5,402 | $65.64 | $354,565 | 213,794 |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 3,158 | $64.68 | $204,274 | 219,196 |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 100 | $66.21 | $6,621 | 222,354 |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M
|
Common Stock | 8,660 | $45.28 | $392,096 | 222,454 |
| 2023-11-06 | MUSSALLEM MICHAEL A | Dir |
Equity grant / award
G
|
Common Stock | 371,689 | $0.00 | $0 | 4,038,377 |
| 2023-11-03 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 176,100 |
| 2023-11-03 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 29,350 | $67.18 | $1,971,733 | 4,486 |
| 2023-11-03 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 43,525 |
| 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,255 | $62.66 | $454,569 | 19,248 |
| 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,503 |
| 2023-10-13 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,660 | $0.00 | $0 | 17,318 |
| 2023-10-13 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 5,150 | $70.26 | $361,864 | 213,794 |
| 2023-10-13 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 3,510 | $69.61 | $244,334 | 218,944 |
| 2023-10-13 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M
|
Common Stock | 8,660 | $45.28 | $392,096 | 222,454 |
| 2023-10-10 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 47,000 |
| 2023-10-10 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 5,000 | $72.68 | $363,400 | 34,814 |
| 2023-10-10 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,000 | $36.75 | $183,750 | 39,814 |
| 2023-10-03 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,500 | $0.00 | $0 | 17,500 |
| 2023-10-03 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 8,500 | $70.00 | $595,000 | 23,950 |
| 2023-10-03 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 8,500 | $59.26 | $503,682 | 32,450 |
| 2023-10-02 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 205,450 |
| 2023-10-02 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 29,350 | $68.84 | $2,020,454 | 4,486 |
| 2023-10-02 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 50,780 |
| 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,255 | $69.54 | $504,527 | 19,248 |
| 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,503 |
| 2023-09-14 | Markowitz Wayne | GM & SVP, Surgical |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 19,256 | $0.00 | $0 | 19,256 |
| 2023-09-14 | Markowitz Wayne | GM & SVP, Surgical |
Equity grant / award
A
|
Common Stock | 7,262 | $0.00 | $0 | 7,262 |
| 2023-09-08 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 52,000 |
| 2023-09-08 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 5,000 | $76.00 | $380,000 | 34,814 |
| 2023-09-08 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,000 | $36.75 | $183,750 | 39,814 |
| 2023-09-06 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,500 | $0.00 | $0 | 26,000 |
| 2023-09-06 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 8,500 | $76.07 | $646,609 | 23,950 |
| 2023-09-06 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 8,500 | $59.26 | $503,682 | 32,450 |
| 2023-09-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 234,800 |
| 2023-09-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 29,350 | $75.86 | $2,226,491 | 4,486 |
| 2023-09-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 33,836 |
| 2023-08-31 | MUSSALLEM MICHAEL A | Dir |
Equity grant / award
G
|
Common Stock | 49,766 | $0.00 | $0 | 3,666,688 |
| 2023-08-29 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 1,500 | $76.69 | $115,040 | 23,950 |
| 2023-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,500 | $0.00 | $0 | 71,500 |
| 2023-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,500 | $79.30 | $356,850 | 39,503 |
| 2023-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 4,500 | $36.75 | $165,375 | 44,003 |
| 2023-08-10 | STONE HEISZ LESLIE | Dir |
Open-market sell
S
|
Common Stock | 3,303 | $78.87 | $260,509 | 26,980 |
| 2023-08-09 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 57,000 |
| 2023-08-09 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 5,000 | $78.64 | $393,185 | 34,814 |
| 2023-08-09 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,000 | $36.75 | $183,750 | 39,814 |
| 2023-08-07 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 264,150 |
| 2023-08-07 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 29,050 | $79.86 | $2,319,933 | 54,252 |
| 2023-08-07 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 300 | $80.54 | $24,162 | 83,302 |
| 2023-08-07 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 83,602 |
| 2023-07-31 | Zovighian Bernard J | CEO |
Other acquired transaction
I
|
Common Stock | 2,559 | $83.54 | $213,744 | 47,111 |
| 2023-07-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,500 | $0.00 | $0 | 76,000 |
| 2023-07-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 3,500 | $92.94 | $325,275 | 39,503 |
| 2023-07-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 3,500 | $36.75 | $128,625 | 43,003 |
| 2023-07-10 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 62,000 |
| 2023-07-10 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 5,000 | $90.52 | $452,600 | 34,814 |
| 2023-07-10 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,000 | $36.75 | $183,750 | 39,814 |
| 2023-07-07 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 252 | $90.46 | $22,796 | 34,814 |
| 2023-07-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 293,500 |
| 2023-07-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 21,728 | $90.63 | $1,969,209 | 54,252 |
| 2023-07-05 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 7,622 | $91.22 | $695,279 | 75,980 |
| 2023-07-05 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 83,602 |
| 2023-06-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,255 | $0.00 | $0 | 72,545 |
| 2023-06-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,255 | $93.27 | $676,674 | 19,248 |
| 2023-06-30 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,255 | $36.75 | $266,621 | 26,503 |
| 2023-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,500 | $0.00 | $0 | 79,500 |
| 2023-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 3,500 | $89.77 | $314,195 | 39,503 |
| 2023-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 3,500 | $36.75 | $128,625 | 43,003 |
| 2023-06-13 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,000 | $0.00 | $0 | 67,000 |
| 2023-06-13 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 5,000 | $85.81 | $429,045 | 35,056 |
| 2023-06-13 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,000 | $36.75 | $183,750 | 40,056 |
| 2023-06-01 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,350 | $0.00 | $0 | 322,850 |
| 2023-06-01 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 18,654 | $84.57 | $1,577,569 | 86,210 |
| 2023-06-01 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 5,396 | $85.08 | $459,092 | 104,864 |
| 2023-06-01 | MUSSALLEM MICHAEL A | Dir |
Open-market sell
S
|
Common Stock | 5,300 | $83.43 | $442,179 | 110,260 |
| 2023-06-01 | MUSSALLEM MICHAEL A | Dir |
Exercise / conversion
M
|
Common Stock | 29,350 | $36.75 | $1,078,612 | 115,560 |
| 2023-05-24 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,421 | $0.00 | $0 | 58,379 |
| 2023-05-24 | Wood Larry L | Global President TAVR & Surg |
Open-market sell
S
|
Common Stock | 6,421 | $84.23 | $540,841 | 213,794 |
| 2023-05-24 | Wood Larry L | Global President TAVR & Surg |
Exercise / conversion
M
|
Common Stock | 6,421 | $45.28 | $290,722 | 220,215 |
| 2023-05-17 | Ullem Scott B. | CVP, Chief Financial Officer |
Equity grant / award
G
|
Common Stock | 8,496 | $0.00 | $0 | 266,318 |
| 2023-05-12 | MUSSALLEM MICHAEL A | Dir |
Equity grant / award
A · derivative
|
Director Stock Option (Right to Acquire) | 3,589 | $0.00 | $0 | 3,589 |
| 2023-05-12 | MUSSALLEM MICHAEL A | Dir |
Equity grant / award
A
|
Common Stock | 4,485 | $0.00 | $0 | 86,210 |
| 2023-05-11 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 5,540 | $0.00 | $0 | 5,540 |
| 2023-05-11 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 1,800 | $0.00 | $0 | 13,036 |
| 2023-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 0 |
| 2023-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 13,891 | $88.29 | $1,226,436 | 81,725 |
| 2023-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,616,922 |
| 2023-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,984 | $88.94 | $532,217 | 105,116 |
| 2023-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 111,100 |
| 2023-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $0.00 | $0 | 83,000 |
| 2023-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 2,500 | $89.22 | $223,050 | 33,078 |
| 2023-05-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 2,500 | $36.75 | $91,875 | 35,578 |
| 2023-05-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Other disposed transaction
F
|
Common Stock | 1,399 | $88.74 | $124,147 | 56,625 |
| 2023-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Performance Rights | 4,767 | $0.00 | $0 | 1,308 |
| 2023-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Other disposed transaction
F
|
Common Stock | 2,968 | $88.74 | $263,380 | 58,024 |
| 2023-05-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 4,767 | $0.00 | $0 | 60,992 |
| 2023-05-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Performance Rights | 20,777 | $0.00 | $0 | 5,698 |
| 2023-05-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 20,777 | $0.00 | $0 | 81,725 |
| 2023-05-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,635 | $88.62 | $499,402 | 56,225 |
| 2023-05-04 | Zovighian Bernard J | President |
Other disposed transaction
F
|
Common Stock | 370 | $88.10 | $32,597 | 20,781 |
| 2023-05-03 | Zovighian Bernard J | President |
Other disposed transaction
F
|
Common Stock | 359 | $87.81 | $31,524 | 21,151 |
| 2023-04-28 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 12,270 | $0.00 | $0 | 0 |
| 2023-04-28 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Open-market sell
S
|
Common Stock | 12,270 | $87.20 | $1,069,944 | 11,750 |
| 2023-04-28 | SELLERS ROBERT W.A. | SVP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 12,270 | $35.20 | $431,864 | 24,020 |
| 2023-04-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 29,375 |
| 2023-04-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,059 | $84.10 | $1,350,562 | 60,948 |
| 2023-04-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,607,422 |
| 2023-04-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,816 | $84.61 | $322,872 | 86,507 |
| 2023-04-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 90,323 |
| 2023-04-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 0 |
| 2023-04-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $83.09 | $558,801 | 62,824 |
| 2023-04-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,549 |
| 2023-03-15 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,435 | $0.00 | $0 | 0 |
| 2023-03-15 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 4,435 | $77.47 | $343,563 | 18,911 |
| 2023-03-15 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 4,435 | $45.28 | $200,802 | 23,346 |
| 2023-03-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 58,750 |
| 2023-03-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,700 | $77.86 | $833,102 | 60,948 |
| 2023-03-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,597,922 |
| 2023-03-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 9,175 | $77.32 | $709,411 | 81,148 |
| 2023-03-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 90,323 |
| 2023-03-08 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,640 | $0.00 | $0 | 13,280 |
| 2023-03-08 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Open-market sell
S
|
Common Stock | 6,590 | $76.95 | $507,125 | 168,875 |
| 2023-03-08 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Open-market sell
S
|
Common Stock | 50 | $77.43 | $3,872 | 175,465 |
| 2023-03-08 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC |
Exercise / conversion
M
|
Common Stock | 6,640 | $35.20 | $233,706 | 175,515 |
| 2023-02-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 335 | $78.51 | $26,301 | 17,784 |
| 2023-02-16 | Wood Larry L | CVP & Grp President TAVR & SSH |
Equity grant / award
A
|
Common Stock | 3,235 | $0.00 | $0 | 205,467 |
| 2023-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 96,405 | $0.00 | $0 | 3,588,422 |
| 2023-02-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 88,125 |
| 2023-02-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,275 | $76.83 | $1,250,408 | 157,353 |
| 2023-02-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,492,017 |
| 2023-02-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,600 | $77.75 | $279,900 | 183,128 |
| 2023-02-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2023-02-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 13,450 |
| 2023-02-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $80.75 | $543,044 | 62,561 |
| 2023-02-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2023-01-17 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,000 | $0.00 | $0 | 8,435 |
| 2023-01-17 | Chopra Daveen | CVP, TMTT |
Open-market sell
S
|
Common Stock | 4,000 | $78.00 | $312,000 | 18,911 |
| 2023-01-17 | Chopra Daveen | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 4,000 | $45.28 | $181,107 | 22,911 |
| 2023-01-13 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 117,500 |
| 2023-01-13 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 19,875 | $78.09 | $1,552,124 | 157,353 |
| 2023-01-13 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,482,517 |
| 2023-01-13 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2023-01-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 20,175 |
| 2023-01-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $77.50 | $521,188 | 62,561 |
| 2023-01-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-12-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,000 | $0.00 | $0 | 12,435 |
| 2022-12-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Open-market sell
S
|
Common Stock | 4,000 | $74.80 | $299,200 | 18,911 |
| 2022-12-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Exercise / conversion
M
|
Common Stock | 4,000 | $45.28 | $181,107 | 22,911 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 146,875 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 12,155 | $76.04 | $924,266 | 157,353 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,473,017 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,420 | $76.93 | $570,821 | 179,008 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 300 | $77.51 | $23,253 | 186,428 |
| 2022-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-12-13 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,236 | $0.00 | $0 | 0 |
| 2022-12-13 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,936 | $76.96 | $533,772 | 202,232 |
| 2022-12-13 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 300 | $77.48 | $23,245 | 209,168 |
| 2022-12-13 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,236 | $36.75 | $265,923 | 209,468 |
| 2022-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 26,900 |
| 2022-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $74.32 | $499,802 | 62,561 |
| 2022-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-11-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,000 | $0.00 | $0 | 16,435 |
| 2022-11-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Open-market sell
S
|
Common Stock | 4,000 | $74.18 | $296,720 | 18,911 |
| 2022-11-15 | Chopra Daveen | CVP, Surgical Structural Heart |
Exercise / conversion
M
|
Common Stock | 4,000 | $45.28 | $181,107 | 22,911 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 176,250 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 15,575 | $73.94 | $1,151,616 | 157,353 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,463,517 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,100 | $74.86 | $306,926 | 182,428 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 200 | $75.47 | $15,094 | 186,528 |
| 2022-11-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 33,625 |
| 2022-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $68.46 | $460,394 | 62,561 |
| 2022-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 205,625 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,497 | $82.41 | $1,194,698 | 157,353 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,454,017 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,978 | $83.38 | $248,306 | 181,350 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,800 | $84.64 | $152,352 | 184,328 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 600 | $85.28 | $51,168 | 186,128 |
| 2022-10-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-10-11 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,242 | $0.00 | $0 | 14,478 |
| 2022-10-11 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,242 | $82.12 | $594,713 | 202,232 |
| 2022-10-11 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,242 | $36.75 | $266,144 | 209,474 |
| 2022-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 40,350 |
| 2022-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $85.00 | $571,625 | 62,561 |
| 2022-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 235,000 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,675 | $84.07 | $1,401,867 | 157,353 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,444,517 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,100 | $84.66 | $262,446 | 183,528 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 100 | $85.25 | $8,526 | 186,628 |
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-09-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 47,075 |
| 2022-09-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $90.94 | $611,572 | 62,561 |
| 2022-09-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-09-06 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,242 | $0.00 | $0 | 21,720 |
| 2022-09-06 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,242 | $89.00 | $644,538 | 202,232 |
| 2022-09-06 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,242 | $36.75 | $266,144 | 209,474 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 264,375 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 15,773 | $104.92 | $1,654,903 | 157,353 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,435,017 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,002 | $104.03 | $416,328 | 182,626 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 100 | $105.41 | $10,541 | 186,628 |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 53,800 |
| 2022-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $105.01 | $706,192 | 62,561 |
| 2022-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-08-05 | Zovighian Bernard J | CVP, TMTT |
Open-market sell
S
|
Common Stock | 4,811 | $103.66 | $498,708 | 21,247 |
| 2022-08-02 | Chopra Daveen | CVP, Surgical Structural Heart |
Open-market sell
S
|
Common Stock | 1,000 | $102.49 | $102,490 | 18,911 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 293,750 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,425,517 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,951 | $96.87 | $770,213 | 166,853 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,000 | $94.56 | $567,360 | 174,804 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,924 | $95.89 | $568,052 | 180,804 |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-07-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 60,525 |
| 2022-07-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,725 | $97.60 | $656,360 | 62,561 |
| 2022-07-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-07-07 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Equity grant / award
A · derivative
|
Performance Rights | 7,625 | $0.00 | $0 | 7,625 |
| 2022-07-07 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 54,500 | $0.00 | $0 | 54,500 |
| 2022-07-07 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Equity grant / award
A
|
Common Stock | 6,100 | $0.00 | $0 | 168,875 |
| 2022-07-05 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,242 | $0.00 | $0 | 36,204 |
| 2022-07-05 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,242 | $95.90 | $694,486 | 202,232 |
| 2022-07-05 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,242 | $36.75 | $266,144 | 209,474 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 29,375 | $0.00 | $0 | 323,125 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,107 | $87.14 | $880,724 | 157,353 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 9,500 | $0.00 | $0 | 3,416,017 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,714 | $86.24 | $579,015 | 176,960 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,054 | $87.92 | $268,508 | 183,674 |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 29,375 | $35.20 | $1,033,903 | 186,728 |
| 2022-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,725 | $0.00 | $0 | 67,250 |
| 2022-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,625 | $89.93 | $505,862 | 62,561 |
| 2022-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 1,100 | $90.50 | $99,547 | 68,186 |
| 2022-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 6,725 | $35.20 | $236,698 | 69,286 |
| 2022-06-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,242 | $0.00 | $0 | 43,446 |
| 2022-06-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 4,479 | $100.19 | $448,738 | 202,199 |
| 2022-06-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 2,763 | $101.09 | $279,315 | 206,678 |
| 2022-06-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,242 | $36.75 | $266,144 | 209,441 |
| 2022-05-31 | Zovighian Bernard J | CVP, TMTT |
Open-market sell
S
|
Common Stock | 9,000 | $100.83 | $907,489 | 30,816 |
| 2022-05-26 | Chopra Daveen | CVP, Surgical Structural Heart |
Open-market sell
S
|
Common Stock | 1,000 | $98.31 | $98,312 | 19,911 |
| 2022-05-24 | Zovighian Bernard J | CVP, TMTT |
Open-market sell
S
|
Common Stock | 4,809 | $95.52 | $459,356 | 39,816 |
| 2022-05-17 | Ullem Scott B. | CVP, Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 1,953 | $95.93 | $187,351 | 29,261 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 0 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 13,098 | $94.54 | $1,238,285 | 157,353 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,406,517 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 12,028 | $95.39 | $1,147,351 | 182,951 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,700 | $93.41 | $439,027 | 194,979 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,724 | $96.12 | $261,831 | 199,679 |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 202,403 |
| 2022-05-08 | Zovighian Bernard J | CVP, TMTT |
Exercise / conversion
M · derivative
|
Performance Rights | 12,600 | $0.00 | $0 | 0 |
| 2022-05-08 | Zovighian Bernard J | CVP, TMTT |
Other disposed transaction
F
|
Common Stock | 6,837 | $100.52 | $687,255 | 46,336 |
| 2022-05-08 | Zovighian Bernard J | CVP, TMTT |
Exercise / conversion
M
|
Common Stock | 12,600 | $0.00 | $0 | 53,173 |
| 2022-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Performance Rights | 56,831 | $0.00 | $0 | 48,712 |
| 2022-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 56,831 | $0.00 | $0 | 157,353 |
| 2022-05-07 | Zovighian Bernard J | CVP, TMTT |
Other disposed transaction
F
|
Common Stock | 633 | $100.52 | $63,629 | 40,573 |
| 2022-05-04 | Zovighian Bernard J | CVP, TMTT |
Other disposed transaction
F
|
Common Stock | 370 | $105.93 | $39,194 | 41,206 |
| 2022-05-04 | GALLAHUE KIERAN | Dir |
Equity grant / award
A
|
Common Stock | 737 | $0.00 | $0 | 3,037 |
| 2022-05-04 | GALLAHUE KIERAN | Dir |
Equity grant / award
A
|
Common Stock | 2,300 | $0.00 | $0 | 2,300 |
| 2022-05-03 | Zovighian Bernard J | CVP, TMTT |
Equity grant / award
A · derivative
|
Performance Rights | 5,200 | $0.00 | $0 | 5,200 |
| 2022-05-03 | Zovighian Bernard J | CVP, TMTT |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 33,700 | $0.00 | $0 | 33,700 |
| 2022-05-03 | Zovighian Bernard J | CVP, TMTT |
Equity grant / award
A
|
Common Stock | 4,150 | $0.00 | $0 | 41,576 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 45,050 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,394,017 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 11,427 | $109.12 | $1,246,914 | 91,772 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,934 | $105.81 | $945,307 | 103,199 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,967 | $107.94 | $859,958 | 112,133 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,276 | $106.86 | $243,213 | 120,100 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,946 | $109.69 | $213,457 | 122,376 |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 124,322 |
| 2022-04-28 | Marsh Martha H. | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 28,722 | $0.00 | $0 | 0 |
| 2022-04-28 | Marsh Martha H. | Dir |
Open-market sell
S
|
Common Stock | 28,722 | $108.09 | $3,104,564 | 26,777 |
| 2022-04-28 | Marsh Martha H. | Dir |
Exercise / conversion
M
|
Common Stock | 28,722 | $25.99 | $746,436 | 55,499 |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 20,000 | $0.00 | $0 | 23,400 |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 9,821 | $121.37 | $1,191,963 | 27,569 |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 6,579 | $123.00 | $809,222 | 37,390 |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,600 | $122.12 | $439,629 | 43,969 |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 20,000 | $21.76 | $435,200 | 47,569 |
| 2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,660 | $0.00 | $0 | 11,560 |
| 2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 11,560 | $123.29 | $1,425,265 | 152,326 |
| 2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 100 | $123.57 | $12,357 | 163,886 |
| 2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 11,660 | $21.76 | $253,722 | 163,986 |
| 2022-04-05 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,242 | $0.00 | $0 | 57,930 |
| 2022-04-05 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 3,867 | $121.52 | $469,917 | 197,641 |
| 2022-04-05 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 2,975 | $120.25 | $357,758 | 201,508 |
| 2022-04-05 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 400 | $122.12 | $48,850 | 204,483 |
| 2022-04-05 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,242 | $36.75 | $266,144 | 204,883 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 90,100 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 22,949 | $112.87 | $2,590,254 | 79,272 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,381,517 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,301 | $112.06 | $481,970 | 114,721 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,000 | $110.86 | $332,580 | 119,022 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,300 | $109.79 | $252,517 | 122,022 |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 124,322 |
| 2022-03-14 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 20,000 | $0.00 | $0 | 43,400 |
| 2022-03-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 11,853 | $104.88 | $1,243,178 | 27,415 |
| 2022-03-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 8,147 | $104.31 | $849,823 | 39,268 |
| 2022-03-14 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 20,000 | $21.76 | $435,200 | 47,415 |
| 2022-03-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 11,050 |
| 2022-03-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,872 | $105.63 | $620,288 | 56,399 |
| 2022-03-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,178 | $106.42 | $551,067 | 62,271 |
| 2022-03-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2022-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,675 | $0.00 | $0 | 40,425 |
| 2022-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,675 | $107.60 | $395,430 | 98,027 |
| 2022-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,675 | $35.20 | $129,348 | 101,702 |
| 2022-02-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 319 | $105.62 | $33,693 | 36,812 |
| 2022-02-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 20,000 | $0.00 | $0 | 63,400 |
| 2022-02-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 13,100 | $106.62 | $1,396,674 | 27,415 |
| 2022-02-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 6,900 | $105.74 | $729,579 | 40,515 |
| 2022-02-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 20,000 | $21.76 | $435,200 | 47,415 |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 135,150 |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 25,756 | $109.95 | $2,831,872 | 79,272 |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,369,017 |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,794 | $110.60 | $751,416 | 117,528 |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 124,322 |
| 2022-02-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 22,100 |
| 2022-02-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 10,650 | $111.47 | $1,187,125 | 56,399 |
| 2022-02-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 400 | $112.00 | $44,799 | 67,049 |
| 2022-02-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2022-02-08 | GALLAHUE KIERAN | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 32,256 | $0.00 | $0 | 0 |
| 2022-02-08 | GALLAHUE KIERAN | Dir |
Open-market sell
S
|
Common Stock | 32,256 | $110.79 | $3,573,510 | 3,433 |
| 2022-02-08 | GALLAHUE KIERAN | Dir |
Exercise / conversion
M
|
Common Stock | 32,256 | $22.29 | $718,880 | 35,689 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 33,150 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,092 | $100.45 | $411,055 | 57,399 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 3,058 | $102.41 | $313,173 | 61,491 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 2,700 | $101.72 | $274,658 | 64,549 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 700 | $99.54 | $69,679 | 67,249 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 500 | $98.23 | $49,117 | 67,949 |
| 2022-01-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 68,449 |
| 2022-01-14 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,000 | $0.00 | $0 | 83,400 |
| 2022-01-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 8,884 | $119.47 | $1,061,329 | 27,415 |
| 2022-01-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 1,116 | $120.01 | $133,934 | 36,299 |
| 2022-01-14 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 10,000 | $21.76 | $217,600 | 37,415 |
| 2022-01-07 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 6,350 |
| 2022-01-07 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $122.16 | $775,716 | 98,027 |
| 2022-01-07 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 104,377 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 180,200 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 19,650 | $123.49 | $2,426,578 | 188,002 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 12,600 | $124.45 | $1,568,070 | 207,652 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,247,787 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 300 | $125.17 | $37,551 | 232,752 |
| 2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-12-22 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 1,000 | $0.00 | $0 | 57,399 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 225,250 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 13,215 | $119.37 | $1,577,475 | 188,002 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 12,809 | $118.37 | $1,516,201 | 201,217 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,235,287 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,526 | $120.09 | $783,707 | 226,526 |
| 2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-12-17 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,000 | $0.00 | $0 | 93,400 |
| 2021-12-17 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 10,000 | $121.24 | $1,212,400 | 27,415 |
| 2021-12-17 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 10,000 | $21.76 | $217,600 | 37,415 |
| 2021-12-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 0 |
| 2021-12-10 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $121.49 | $951,267 | 197,432 |
| 2021-12-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 205,262 |
| 2021-11-29 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 100 | $0.00 | $0 | 34,880 |
| 2021-11-29 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 100 | $110.58 | $11,058 | 152,103 |
| 2021-11-29 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 100 | $21.76 | $2,176 | 152,203 |
| 2021-11-24 | VALERIANI NICHOLAS J | Dir |
Open-market buy
P
|
Common Stock | 1,500 | $112.23 | $168,345 | 63,811 |
| 2021-11-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,000 | $0.00 | $0 | 103,400 |
| 2021-11-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 6,357 | $117.88 | $749,394 | 27,415 |
| 2021-11-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,390 | $116.98 | $279,586 | 33,772 |
| 2021-11-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 1,253 | $118.87 | $148,947 | 36,162 |
| 2021-11-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 10,000 | $21.76 | $217,600 | 37,415 |
| 2021-11-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 7,830 |
| 2021-11-10 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $119.79 | $937,956 | 372,134 |
| 2021-11-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 379,964 |
| 2021-11-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 270,300 |
| 2021-11-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 18,428 | $119.70 | $2,205,832 | 188,002 |
| 2021-11-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,122 | $120.17 | $1,697,041 | 206,430 |
| 2021-11-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,222,787 |
| 2021-11-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-11-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 19,050 |
| 2021-11-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $119.40 | $758,190 | 98,027 |
| 2021-11-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 104,377 |
| 2021-11-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 55,250 |
| 2021-11-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 6,459 | $116.81 | $754,444 | 56,399 |
| 2021-11-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,591 | $117.68 | $540,264 | 62,858 |
| 2021-11-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2021-10-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 9,741 | $0.00 | $0 | 113,400 |
| 2021-10-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 7,138 | $110.24 | $786,883 | 27,415 |
| 2021-10-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,603 | $110.87 | $288,599 | 34,553 |
| 2021-10-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 9,741 | $21.76 | $211,964 | 37,156 |
| 2021-10-11 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 15,660 |
| 2021-10-11 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $108.00 | $845,640 | 372,134 |
| 2021-10-11 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 379,964 |
| 2021-10-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 66,300 |
| 2021-10-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 10,950 | $110.48 | $1,209,776 | 56,399 |
| 2021-10-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 100 | $111.06 | $11,106 | 67,349 |
| 2021-10-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 315,350 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 18,118 | $111.34 | $2,017,258 | 188,002 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,132 | $112.17 | $1,585,186 | 206,120 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,210,287 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 300 | $113.10 | $33,930 | 232,752 |
| 2021-10-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-09-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 360,400 |
| 2021-09-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 27,567 | $121.29 | $3,343,601 | 188,002 |
| 2021-09-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,197,787 |
| 2021-09-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,983 | $120.53 | $600,601 | 228,069 |
| 2021-09-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-09-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 77,350 |
| 2021-09-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 10,708 | $122.23 | $1,308,892 | 56,399 |
| 2021-09-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 342 | $122.76 | $41,982 | 67,107 |
| 2021-09-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2021-09-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 31,750 |
| 2021-09-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $121.25 | $769,947 | 98,027 |
| 2021-09-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 104,377 |
| 2021-08-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 31,320 |
| 2021-08-10 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $114.14 | $893,678 | 372,134 |
| 2021-08-10 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 379,964 |
| 2021-08-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 7,000 | $0.00 | $0 | 117,320 |
| 2021-08-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 38,100 |
| 2021-08-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $115.54 | $733,679 | 98,027 |
| 2021-08-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 104,377 |
| 2021-08-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 88,400 |
| 2021-08-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 11,050 | $114.37 | $1,263,763 | 56,399 |
| 2021-08-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2021-08-05 | Szyman Catherine M. | CVP, Critical Care |
Equity grant / award
G
|
Common Stock | 344 | $0.00 | $0 | 27,415 |
| 2021-08-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 405,450 |
| 2021-08-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 18,293 | $114.41 | $2,092,902 | 188,002 |
| 2021-08-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,257 | $113.80 | $1,622,447 | 206,295 |
| 2021-08-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,185,287 |
| 2021-08-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-08-02 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 15,000 | $0.00 | $0 | 132,882 |
| 2021-08-02 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 15,000 | $113.53 | $1,702,904 | 27,759 |
| 2021-08-02 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 15,000 | $21.76 | $326,400 | 42,759 |
| 2021-07-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 39,150 |
| 2021-07-12 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $107.48 | $841,568 | 372,134 |
| 2021-07-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 379,964 |
| 2021-07-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,050 | $0.00 | $0 | 99,450 |
| 2021-07-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 11,050 | $108.15 | $1,195,111 | 56,399 |
| 2021-07-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 11,050 | $21.76 | $240,448 | 67,449 |
| 2021-07-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 44,450 |
| 2021-07-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $106.72 | $677,672 | 98,027 |
| 2021-07-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 104,377 |
| 2021-07-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 450,500 |
| 2021-07-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,382 | $104.78 | $1,716,506 | 188,002 |
| 2021-07-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,168 | $104.43 | $1,688,424 | 204,384 |
| 2021-07-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,172,787 |
| 2021-07-01 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-06-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,410 | $0.00 | $0 | 0 |
| 2021-06-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,410 | $101.17 | $344,990 | 27,705 |
| 2021-06-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 3,410 | $22.29 | $75,998 | 31,115 |
| 2021-06-14 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 46,980 |
| 2021-06-14 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $99.91 | $782,295 | 372,072 |
| 2021-06-14 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 379,902 |
| 2021-06-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 45,050 | $0.00 | $0 | 495,550 |
| 2021-06-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 32,550 | $97.23 | $3,164,836 | 188,002 |
| 2021-06-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 3,160,287 |
| 2021-06-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 45,050 | $21.76 | $980,288 | 233,052 |
| 2021-05-28 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,061 | $95.29 | $196,393 | 27,705 |
| 2021-05-25 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 4,665 | $96.09 | $448,300 | 29,766 |
| 2021-05-24 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 33,000 | $0.00 | $0 | 540,600 |
| 2021-05-24 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 26,377 | $95.55 | $2,520,322 | 188,002 |
| 2021-05-24 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,623 | $96.13 | $636,669 | 214,379 |
| 2021-05-24 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 33,000 | $21.76 | $718,080 | 221,002 |
| 2021-05-17 | Chopra Daveen | CVP, Surgical Structural Heart |
Other disposed transaction
F
|
Common Stock | 1,146 | $89.49 | $102,556 | 15,827 |
| 2021-05-11 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Other disposed transaction
F
|
Common Stock | 143 | $90.40 | $12,927 | 142,197 |
| 2021-05-07 | Ullem Scott B. | CVP, Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 538 | $91.75 | $49,362 | 31,676 |
| 2021-05-05 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 65,550 | $0.00 | $0 | 0 |
| 2021-05-05 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 33,450 | $92.23 | $3,085,094 | 97,015 |
| 2021-05-05 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 3,147,787 |
| 2021-05-05 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,100 | $93.00 | $195,300 | 160,465 |
| 2021-05-05 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 65,550 | $13.98 | $916,389 | 162,565 |
| 2021-05-05 | LAVIOLETTE PAUL A | Dir |
Equity grant / award
A
|
Common Stock | 2,615 | $0.00 | $0 | 2,615 |
| 2021-05-04 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 4,250 | $0.00 | $0 | 4,250 |
| 2021-05-04 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 1,340 | $0.00 | $0 | 11,167 |
| 2021-04-27 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 114,205 | $0.00 | $0 | 3,117,787 |
| 2021-04-23 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 12,000 | $97.66 | $1,171,976 | 20,409 |
| 2021-04-22 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,389 | $0.00 | $0 | 6,799 |
| 2021-04-22 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,389 | $94.40 | $319,922 | 26,966 |
| 2021-04-22 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 3,389 | $22.29 | $75,530 | 30,355 |
| 2021-04-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 62,640 |
| 2021-04-12 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $85.84 | $672,108 | 363,783 |
| 2021-04-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 371,613 |
| 2021-04-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,077 | $0.00 | $0 | 0 |
| 2021-04-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 13,077 | $84.27 | $1,102,046 | 48,845 |
| 2021-04-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,077 | $13.98 | $182,816 | 61,922 |
| 2021-04-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 65,550 |
| 2021-04-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 68,550 | $84.45 | $5,789,048 | 211,220 |
| 2021-04-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 3,003,582 |
| 2021-04-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2021-04-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,020 | $0.00 | $0 | 0 |
| 2021-04-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 13,020 | $83.66 | $1,089,264 | 139,541 |
| 2021-04-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 13,020 | $13.98 | $182,020 | 152,561 |
| 2021-03-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,389 | $0.00 | $0 | 10,188 |
| 2021-03-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,389 | $81.66 | $276,746 | 26,746 |
| 2021-03-15 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 3,389 | $22.29 | $75,530 | 30,135 |
| 2021-03-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,077 | $0.00 | $0 | 13,077 |
| 2021-03-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 13,077 | $82.85 | $1,083,375 | 48,508 |
| 2021-03-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,077 | $13.98 | $182,816 | 61,585 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 164,100 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 39,262 | $82.43 | $3,236,367 | 211,220 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,973,582 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 26,288 | $83.15 | $2,185,847 | 280,482 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,000 | $81.47 | $244,410 | 306,770 |
| 2021-03-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2021-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,350 | $0.00 | $0 | 69,850 |
| 2021-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 6,350 | $81.37 | $516,700 | 93,213 |
| 2021-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 6,350 | $21.76 | $138,176 | 99,563 |
| 2021-03-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,830 | $0.00 | $0 | 70,470 |
| 2021-03-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 7,830 | $83.99 | $657,642 | 363,483 |
| 2021-03-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 7,830 | $35.20 | $275,590 | 371,313 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 262,650 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,943,582 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 29,453 | $85.07 | $2,505,567 | 241,220 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 24,471 | $83.19 | $2,035,742 | 270,673 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,426 | $83.98 | $1,211,495 | 295,144 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 200 | $85.58 | $17,116 | 309,570 |
| 2021-02-23 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2021-02-16 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,389 | $0.00 | $0 | 13,577 |
| 2021-02-16 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,389 | $88.20 | $298,910 | 26,746 |
| 2021-02-16 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 3,389 | $22.29 | $75,530 | 30,135 |
| 2021-02-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,661 | $0.00 | $0 | 0 |
| 2021-02-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 11,745 | $86.81 | $1,019,583 | 93,213 |
| 2021-02-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,661 | $13.98 | $163,021 | 104,958 |
| 2021-02-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,077 | $0.00 | $0 | 26,154 |
| 2021-02-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 13,077 | $85.80 | $1,121,996 | 48,508 |
| 2021-02-05 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,077 | $13.98 | $182,816 | 61,585 |
| 2021-02-04 | VALERIANI NICHOLAS J | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 22,608 | $0.00 | $0 | 0 |
| 2021-02-04 | VALERIANI NICHOLAS J | Dir |
Open-market sell
S
|
Common Stock | 8,200 | $85.21 | $698,752 | 59,696 |
| 2021-02-04 | VALERIANI NICHOLAS J | Dir |
Exercise / conversion
M
|
Common Stock | 22,608 | $20.76 | $469,304 | 67,896 |
| 2021-02-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,020 | $0.00 | $0 | 26,040 |
| 2021-02-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,503 | $0.00 | $0 | 0 |
| 2021-02-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 20,523 | $83.51 | $1,713,787 | 139,221 |
| 2021-02-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 7,503 | $11.35 | $85,159 | 159,744 |
| 2021-02-01 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 13,020 | $13.98 | $182,020 | 152,241 |
| 2021-01-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 361,200 |
| 2021-01-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 63,242 | $87.46 | $5,531,145 | 211,220 |
| 2021-01-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,913,582 |
| 2021-01-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,308 | $87.93 | $466,732 | 304,462 |
| 2021-01-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2021-01-15 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,649 | $0.00 | $0 | 11,661 |
| 2021-01-15 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 11,730 | $87.27 | $1,023,677 | 93,297 |
| 2021-01-15 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,649 | $13.98 | $162,853 | 105,027 |
| 2021-01-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,077 | $0.00 | $0 | 39,231 |
| 2021-01-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 8,400 | $90.22 | $757,849 | 48,508 |
| 2021-01-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,677 | $90.85 | $424,907 | 56,908 |
| 2021-01-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,077 | $13.98 | $182,816 | 61,585 |
| 2021-01-04 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,020 | $0.00 | $0 | 39,060 |
| 2021-01-04 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,503 | $0.00 | $0 | 7,503 |
| 2021-01-04 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 20,523 | $91.24 | $1,872,475 | 139,221 |
| 2021-01-04 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 7,503 | $11.35 | $85,159 | 159,744 |
| 2021-01-04 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 13,020 | $13.98 | $182,020 | 152,241 |
| 2020-12-15 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,722 | $0.00 | $0 | 0 |
| 2020-12-15 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 9,922 | $84.16 | $835,035 | 363,483 |
| 2020-12-15 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 800 | $84.83 | $67,860 | 373,405 |
| 2020-12-15 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,722 | $21.76 | $233,311 | 374,205 |
| 2020-12-14 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 279,570 |
| 2020-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,074 | $0.00 | $0 | 52,308 |
| 2020-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 12,774 | $84.63 | $1,081,021 | 48,508 |
| 2020-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 300 | $85.59 | $25,678 | 61,282 |
| 2020-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,074 | $13.98 | $182,775 | 61,582 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 558,300 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 35,205 | $85.19 | $2,999,114 | 211,220 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 30,345 | $84.82 | $2,573,863 | 246,425 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,853,582 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,400 | $86.51 | $207,624 | 306,770 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 600 | $87.37 | $52,422 | 309,170 |
| 2020-11-17 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-11-16 | LORANGER STEVEN R | Dir |
Exercise / conversion
M · derivative
|
Director Stock Option (Right to Acquire) | 19,797 | $0.00 | $0 | 0 |
| 2020-11-16 | LORANGER STEVEN R | Dir |
Exercise / conversion
M
|
Common Stock | 19,797 | $35.20 | $696,789 | 46,965 |
| 2020-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,074 | $0.00 | $0 | 65,382 |
| 2020-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 12,213 | $80.52 | $983,441 | 48,508 |
| 2020-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 861 | $81.09 | $69,819 | 60,721 |
| 2020-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,074 | $13.98 | $182,775 | 61,582 |
| 2020-11-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,649 | $0.00 | $0 | 34,959 |
| 2020-11-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 8,290 | $81.01 | $671,606 | 93,462 |
| 2020-11-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,359 | $81.76 | $274,632 | 101,752 |
| 2020-11-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 81 | $81.76 | $6,623 | 105,111 |
| 2020-11-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,649 | $13.98 | $162,853 | 105,192 |
| 2020-11-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 227 | $83.89 | $19,030 | 403 |
| 2020-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 347 | $78.01 | $27,069 | 630 |
| 2020-11-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 10,722 |
| 2020-11-02 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 10,698 | $73.27 | $783,806 | 363,483 |
| 2020-11-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,181 |
| 2020-10-29 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 20,355 | $0.00 | $0 | 20,355 |
| 2020-10-29 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 20,355 | $73.24 | $1,490,884 | 26,746 |
| 2020-10-29 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 20,355 | $22.29 | $453,646 | 47,101 |
| 2020-10-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 33,150 | $0.00 | $0 | 0 |
| 2020-10-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 19,229 | $79.20 | $1,522,989 | 27,114 |
| 2020-10-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 13,921 | $78.26 | $1,089,400 | 46,343 |
| 2020-10-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 33,150 | $21.76 | $721,344 | 60,264 |
| 2020-10-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 33,150 | $0.00 | $0 | 33,150 |
| 2020-10-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 27,500 | $83.69 | $2,301,544 | 27,114 |
| 2020-10-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 5,650 | $84.37 | $476,673 | 54,614 |
| 2020-10-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 33,150 | $21.76 | $721,344 | 60,264 |
| 2020-10-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 656,850 |
| 2020-10-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,823,582 |
| 2020-10-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 43,250 | $83.60 | $3,615,700 | 241,220 |
| 2020-10-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 25,300 | $82.50 | $2,087,250 | 284,470 |
| 2020-10-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-10-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 21,420 |
| 2020-10-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 10,698 | $80.38 | $859,905 | 363,483 |
| 2020-10-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,181 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 755,400 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,793,582 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 45,350 | $78.42 | $3,556,347 | 241,220 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 22,802 | $79.36 | $1,809,567 | 286,570 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 398 | $79.99 | $31,836 | 309,372 |
| 2020-09-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-09-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 33,150 | $0.00 | $0 | 66,300 |
| 2020-09-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 33,150 | $78.11 | $2,589,204 | 27,114 |
| 2020-09-28 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 33,150 | $21.76 | $721,344 | 60,264 |
| 2020-09-15 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 33,150 | $0.00 | $0 | 99,450 |
| 2020-09-15 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 33,150 | $83.43 | $2,765,748 | 27,114 |
| 2020-09-15 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 33,150 | $21.76 | $721,344 | 60,264 |
| 2020-09-14 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 26,700 | $0.00 | $0 | 0 |
| 2020-09-14 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 26,700 | $82.21 | $2,194,908 | 27,114 |
| 2020-09-14 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 26,700 | $13.98 | $373,266 | 53,814 |
| 2020-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,074 | $0.00 | $0 | 91,530 |
| 2020-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 12,198 | $82.42 | $1,005,364 | 48,508 |
| 2020-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 876 | $82.90 | $72,624 | 60,706 |
| 2020-09-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,074 | $13.98 | $182,775 | 61,582 |
| 2020-09-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 32,118 |
| 2020-09-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 10,698 | $85.09 | $910,293 | 363,483 |
| 2020-09-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,181 |
| 2020-08-28 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 7,200 | $84.26 | $606,694 | 123,820 |
| 2020-08-27 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 21,540 | $0.00 | $0 | 0 |
| 2020-08-27 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 21,540 | $82.60 | $1,779,161 | 42,040 |
| 2020-08-27 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 21,540 | $21.76 | $468,710 | 63,580 |
| 2020-08-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 853,950 |
| 2020-08-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,763,582 |
| 2020-08-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 59,750 | $78.97 | $4,718,458 | 241,220 |
| 2020-08-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,800 | $79.57 | $700,216 | 300,970 |
| 2020-08-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,074 | $0.00 | $0 | 104,604 |
| 2020-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 13,074 | $78.75 | $1,029,605 | 48,508 |
| 2020-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,074 | $13.98 | $182,775 | 61,582 |
| 2020-08-13 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,249 | $78.24 | $175,962 | 26,746 |
| 2020-08-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 5,000 | $0.00 | $0 | 131,020 |
| 2020-08-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 24,324 | $0.00 | $0 | 136,020 |
| 2020-08-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,649 | $0.00 | $0 | 69,906 |
| 2020-08-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 11,649 | $76.04 | $885,793 | 93,708 |
| 2020-08-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 84 | $76.47 | $6,423 | 105,357 |
| 2020-08-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,649 | $13.98 | $162,853 | 105,441 |
| 2020-08-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 12,000 | $77.28 | $927,378 | 111,696 |
| 2020-08-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 42,816 |
| 2020-08-03 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 10,698 | $78.40 | $838,717 | 363,483 |
| 2020-08-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,181 |
| 2020-07-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,249 | $67.66 | $152,167 | 28,995 |
| 2020-07-10 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,649 | $0.00 | $0 | 81,555 |
| 2020-07-10 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 9,643 | $67.30 | $649,002 | 93,792 |
| 2020-07-10 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 2,006 | $68.21 | $136,820 | 103,435 |
| 2020-07-10 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,649 | $13.98 | $162,853 | 105,441 |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 952,500 |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,733,582 |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 41,407 | $68.01 | $2,816,090 | 241,220 |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 27,143 | $68.54 | $1,860,381 | 282,627 |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-07-06 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 26,700 | $0.00 | $0 | 53,400 |
| 2020-07-06 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 26,700 | $69.98 | $1,868,389 | 27,114 |
| 2020-07-06 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 26,700 | $13.98 | $373,266 | 53,814 |
| 2020-07-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 53,514 |
| 2020-07-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 9,393 | $68.82 | $646,456 | 363,483 |
| 2020-07-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 1,305 | $69.47 | $90,657 | 372,876 |
| 2020-07-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,181 |
| 2020-06-22 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 26,700 | $0.00 | $0 | 80,100 |
| 2020-06-22 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 24,479 | $69.45 | $1,700,037 | 27,114 |
| 2020-06-22 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 2,221 | $70.19 | $155,891 | 51,593 |
| 2020-06-22 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 26,700 | $13.98 | $373,266 | 53,814 |
| 2020-06-16 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 3,348 | $70.67 | $236,603 | 31,216 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 98,550 | $0.00 | $0 | 1,051,050 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 2,703,582 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 37,312 | $68.81 | $2,567,439 | 241,220 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 21,938 | $67.65 | $1,484,106 | 278,532 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,200 | $66.91 | $414,842 | 300,470 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,100 | $69.00 | $213,900 | 306,670 |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 98,550 | $13.98 | $1,377,729 | 309,770 |
| 2020-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 13,074 | $0.00 | $0 | 130,752 |
| 2020-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 13,074 | $69.86 | $913,313 | 72,752 |
| 2020-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 13,074 | $13.98 | $182,775 | 85,826 |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 11,649 | $0.00 | $0 | 93,204 |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 8,362 | $71.25 | $595,792 | 94,221 |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,287 | $72.42 | $238,053 | 102,583 |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 84 | $72.59 | $6,098 | 105,870 |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 11,649 | $13.98 | $162,853 | 105,954 |
| 2020-06-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,698 | $0.00 | $0 | 64,212 |
| 2020-06-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 10,698 | $75.30 | $805,559 | 363,399 |
| 2020-06-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 10,698 | $21.76 | $232,788 | 374,097 |
| 2020-05-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Equity grant / award
G
|
Common Stock | 14,487 | $0.00 | $0 | 229,251 |
| 2020-05-18 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 1,717 | $216.68 | $372,040 | 31,435 |
| 2020-05-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,358 | $0.00 | $0 | 47,942 |
| 2020-05-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,358 | $215.16 | $937,667 | 24,251 |
| 2020-05-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 4,358 | $41.94 | $182,775 | 28,609 |
| 2020-05-14 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 1,116 | $212.69 | $237,362 | 12,271 |
| 2020-05-13 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 750 | $216.93 | $162,698 | 13,387 |
| 2020-05-12 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 682 | $225.05 | $153,484 | 14,137 |
| 2020-05-11 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Performance Rights | 5,950 | $0.00 | $0 | 0 |
| 2020-05-11 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 2,951 | $217.84 | $642,846 | 14,819 |
| 2020-05-11 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 548 | $217.84 | $119,376 | 17,770 |
| 2020-05-11 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 5,950 | $0.00 | $0 | 18,318 |
| 2020-05-08 | STONE HEISZ LESLIE | Dir |
Equity grant / award
A · derivative
|
Director Stock Option (Right to Acquire) | 1,033 | $0.00 | $0 | 1,033 |
| 2020-05-08 | STONE HEISZ LESLIE | Dir |
Equity grant / award
A
|
Common Stock | 1,101 | $0.00 | $0 | 6,424 |
| 2020-05-07 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 1,700 | $0.00 | $0 | 1,700 |
| 2020-05-07 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Equity grant / award
A
|
Common Stock | 515 | $0.00 | $0 | 14,118 |
| 2020-05-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,566 | $0.00 | $0 | 24,970 |
| 2020-05-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 3,566 | $215.00 | $766,690 | 117,536 |
| 2020-05-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 3,566 | $65.28 | $232,788 | 121,102 |
| 2020-04-30 | Szyman Catherine M. | CVP, Critical Care |
Equity grant / award
G
|
Common Stock | 3,987 | $0.00 | $0 | 10,768 |
| 2020-04-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,470 | $0.00 | $0 | 0 |
| 2020-04-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 3,470 | $223.50 | $775,545 | 41,931 |
| 2020-04-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 3,470 | $35.78 | $124,174 | 45,401 |
| 2020-04-16 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 1,116 | $216.91 | $242,072 | 14,755 |
| 2020-04-13 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,883 | $0.00 | $0 | 38,834 |
| 2020-04-13 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,911 | $212.99 | $833,004 | 31,236 |
| 2020-04-13 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,883 | $41.94 | $162,853 | 35,147 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 32,850 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 881,194 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,400 | $205.20 | $902,880 | 47,126 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,731 | $204.29 | $762,206 | 51,526 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,499 | $203.35 | $711,522 | 55,257 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,400 | $201.21 | $482,904 | 58,756 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,300 | $202.40 | $465,520 | 61,156 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,000 | $199.27 | $398,540 | 63,456 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,300 | $200.26 | $260,338 | 65,456 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 905 | $196.15 | $177,516 | 66,756 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 800 | $197.16 | $157,728 | 67,661 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 700 | $206.14 | $144,298 | 68,461 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 415 | $194.91 | $80,888 | 69,161 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 400 | $197.57 | $79,028 | 69,576 |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 69,976 |
| 2020-04-03 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 5,372 |
| 2020-04-03 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $182.44 | $979,520 | 20,822 |
| 2020-04-03 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,191 |
| 2020-04-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,566 | $0.00 | $0 | 28,536 |
| 2020-04-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 3,566 | $180.84 | $644,875 | 117,536 |
| 2020-04-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 3,566 | $65.28 | $232,788 | 121,102 |
| 2020-03-30 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,883 | $0.00 | $0 | 42,717 |
| 2020-03-30 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,948 | $198.10 | $980,280 | 31,183 |
| 2020-03-30 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,883 | $41.94 | $162,853 | 36,131 |
| 2020-03-23 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 1,116 | $162.95 | $181,852 | 15,773 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $35.78 | $1,175,537 | 65,700 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 871,194 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,787 | $180.45 | $863,814 | 47,126 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,950 | $181.38 | $535,071 | 51,913 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,200 | $177.29 | $390,038 | 54,863 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,100 | $172.82 | $362,922 | 57,063 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,600 | $174.97 | $279,952 | 61,263 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,213 | $179.57 | $217,818 | 62,863 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $171.90 | $206,280 | 64,076 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,000 | $176.31 | $176,310 | 66,476 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 900 | $183.94 | $165,546 | 67,476 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 700 | $170.81 | $119,567 | 68,376 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 200 | $169.52 | $33,904 | 69,776 |
| 2020-03-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 69,976 |
| 2020-03-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 10,741 |
| 2020-03-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $201.90 | $1,084,001 | 20,713 |
| 2020-03-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2020-03-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,566 | $0.00 | $0 | 32,102 |
| 2020-03-02 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 3,566 | $207.00 | $738,162 | 117,429 |
| 2020-03-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 3,566 | $65.28 | $232,788 | 120,995 |
| 2020-02-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,470 | $0.00 | $0 | 6,940 |
| 2020-02-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 3,470 | $217.53 | $754,829 | 41,818 |
| 2020-02-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 3,470 | $35.78 | $124,174 | 45,288 |
| 2020-02-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $0.00 | $0 | 13,570 |
| 2020-02-18 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,500 | $228.57 | $571,425 | 16,889 |
| 2020-02-18 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 2,500 | $66.86 | $167,150 | 19,389 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $35.78 | $1,175,537 | 98,550 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 861,194 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,794 | $230.85 | $1,799,265 | 47,126 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,300 | $227.76 | $1,207,122 | 54,920 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,149 | $228.56 | $948,284 | 60,220 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,100 | $230.04 | $943,146 | 64,369 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,507 | $231.51 | $348,891 | 68,469 |
| 2020-02-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 69,976 |
| 2020-02-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 16,110 |
| 2020-02-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $235.65 | $1,265,205 | 20,713 |
| 2020-02-07 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2020-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 0 |
| 2020-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $227.31 | $1,056,992 | 32,248 |
| 2020-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2020-02-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,566 | $0.00 | $0 | 35,668 |
| 2020-02-03 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 3,566 | $219.50 | $782,737 | 117,429 |
| 2020-02-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 3,566 | $65.28 | $232,788 | 120,995 |
| 2020-01-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 21,479 |
| 2020-01-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $235.69 | $1,265,420 | 20,713 |
| 2020-01-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2020-01-07 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 35,600 |
| 2020-01-07 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $234.25 | $1,756,875 | 9,938 |
| 2020-01-07 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 17,438 |
| 2020-01-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 4,650 |
| 2020-01-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $230.95 | $1,073,918 | 32,248 |
| 2020-01-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $35.78 | $1,175,537 | 131,400 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 851,194 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,444 | $232.02 | $2,423,193 | 47,126 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,830 | $231.30 | $1,811,082 | 57,570 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,376 | $230.21 | $777,183 | 65,400 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $229.35 | $275,215 | 68,776 |
| 2020-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 69,976 |
| 2020-01-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,566 | $0.00 | $0 | 39,234 |
| 2020-01-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,002 | $0.00 | $0 | 0 |
| 2020-01-02 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 8,568 | $229.98 | $1,970,469 | 117,429 |
| 2020-01-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 3,566 | $65.28 | $232,788 | 125,997 |
| 2020-01-02 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 5,002 | $34.05 | $170,318 | 122,431 |
| 2019-12-16 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $0.00 | $0 | 18,570 |
| 2019-12-16 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,500 | $234.27 | $585,686 | 17,105 |
| 2019-12-16 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 2,500 | $66.86 | $167,150 | 19,605 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 164,250 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 841,194 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,883 | $230.48 | $2,047,347 | 47,126 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,808 | $229.40 | $1,561,752 | 56,009 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,648 | $228.53 | $1,519,242 | 62,817 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 511 | $231.02 | $118,050 | 69,465 |
| 2019-12-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 69,976 |
| 2019-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 26,848 |
| 2019-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $229.26 | $1,230,897 | 20,713 |
| 2019-12-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2019-12-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 43,100 |
| 2019-12-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $233.88 | $1,754,100 | 9,938 |
| 2019-12-10 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 17,438 |
| 2019-12-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 9,300 |
| 2019-12-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $238.56 | $1,109,304 | 32,248 |
| 2019-12-09 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 197,100 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 35,794 | $0.00 | $0 | 831,194 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 13,100 | $244.63 | $3,204,678 | 72,920 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,985 | $245.38 | $1,223,228 | 86,020 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,965 | $243.66 | $966,093 | 91,005 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 800 | $242.68 | $194,144 | 94,970 |
| 2019-11-15 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 95,770 |
| 2019-11-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 50,600 |
| 2019-11-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $234.28 | $1,757,100 | 9,938 |
| 2019-11-12 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 17,438 |
| 2019-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 32,217 |
| 2019-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $234.37 | $1,258,333 | 20,713 |
| 2019-11-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2019-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,500 | $0.00 | $0 | 52,300 |
| 2019-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 8,000 | $234.52 | $1,876,182 | 20,713 |
| 2019-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 2,500 | $234.88 | $587,199 | 28,713 |
| 2019-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 10,500 | $41.94 | $440,370 | 31,213 |
| 2019-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 13,950 |
| 2019-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $234.83 | $1,091,960 | 32,248 |
| 2019-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-11-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 6,724 |
| 2019-11-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $239.75 | $1,610,161 | 117,429 |
| 2019-11-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 124,145 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 229,950 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 795,400 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 13,115 | $238.75 | $3,131,229 | 72,920 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,900 | $239.52 | $1,413,154 | 86,035 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,835 | $237.80 | $911,963 | 91,935 |
| 2019-10-30 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 95,770 |
| 2019-10-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 58,100 |
| 2019-10-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $235.30 | $1,764,750 | 9,938 |
| 2019-10-29 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 17,438 |
| 2019-10-25 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $66.86 | $167,150 | 23,570 |
| 2019-10-25 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,500 | $227.19 | $567,975 | 17,105 |
| 2019-10-25 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 2,500 | $66.86 | $167,150 | 19,605 |
| 2019-10-25 | Ullem Scott B. | CVP, Chief Financial Officer |
Equity grant / award
G
|
Common Stock | 3,626 | $0.00 | $0 | 71,588 |
| 2019-10-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 18,600 |
| 2019-10-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $223.18 | $1,037,787 | 32,248 |
| 2019-10-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-10-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 13,440 |
| 2019-10-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $218.24 | $1,465,700 | 117,429 |
| 2019-10-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 124,145 |
| 2019-09-19 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,500 | $0.00 | $0 | 26,070 |
| 2019-09-19 | Szyman Catherine M. | CVP, Critical Care |
Equity grant / award
G
|
Common Stock | 583 | $0.00 | $0 | 17,055 |
| 2019-09-19 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 2,500 | $216.71 | $541,775 | 17,638 |
| 2019-09-19 | Szyman Catherine M. | CVP, Critical Care |
Exercise / conversion
M
|
Common Stock | 2,500 | $66.86 | $167,150 | 20,138 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 262,800 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 785,400 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,400 | $216.43 | $1,818,013 | 72,920 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,656 | $217.42 | $794,902 | 81,320 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,400 | $215.66 | $517,592 | 84,976 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,194 | $213.23 | $467,829 | 87,376 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,100 | $214.16 | $449,736 | 89,570 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,500 | $208.70 | $313,050 | 91,670 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $211.10 | $253,316 | 93,170 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,000 | $212.20 | $212,196 | 94,370 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 400 | $209.74 | $83,894 | 95,370 |
| 2019-09-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 95,770 |
| 2019-09-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 65,600 |
| 2019-09-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $225.74 | $1,693,050 | 13,564 |
| 2019-09-09 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 21,064 |
| 2019-09-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 42,955 |
| 2019-09-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $226.26 | $1,214,790 | 20,713 |
| 2019-09-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2019-09-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 23,250 |
| 2019-09-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $222.06 | $1,032,579 | 32,248 |
| 2019-09-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-09-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 20,156 |
| 2019-09-03 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $219.91 | $1,476,916 | 117,429 |
| 2019-09-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 124,145 |
| 2019-08-30 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 334 | $222.00 | $74,148 | 0 |
| 2019-08-30 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $222.00 | $82,584 | 17,638 |
| 2019-08-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,500 | $0.00 | $0 | 73,100 |
| 2019-08-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Open-market sell
S
|
Common Stock | 7,500 | $213.44 | $1,600,800 | 13,564 |
| 2019-08-26 | Ullem Scott B. | CVP, Chief Financial Officer |
Exercise / conversion
M
|
Common Stock | 7,500 | $41.94 | $314,550 | 21,064 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 361,350 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 775,400 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 9,825 | $216.37 | $2,125,813 | 72,920 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,600 | $214.25 | $557,047 | 82,745 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,525 | $215.41 | $543,915 | 85,345 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,099 | $220.76 | $463,370 | 87,870 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,700 | $217.02 | $368,927 | 89,969 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 800 | $219.65 | $175,723 | 93,369 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 700 | $212.04 | $148,430 | 94,169 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 601 | $221.34 | $133,023 | 94,869 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 300 | $212.97 | $63,891 | 95,470 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 95,770 |
| 2019-08-22 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 295,650 |
| 2019-08-21 | LINK WILLIAM J PHD | Dir |
Open-market sell
S
|
Common Stock | 1,650 | $222.02 | $366,328 | 4,722 |
| 2019-08-21 | LINK WILLIAM J PHD | Dir |
Open-market sell
S
|
Common Stock | 6,914 | $221.56 | $1,531,862 | 9,903 |
| 2019-08-20 | LINK WILLIAM J PHD | Dir |
Open-market sell
S
|
Common Stock | 1,650 | $222.98 | $367,919 | 16,817 |
| 2019-08-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 328 | $214.53 | $70,366 | 334 |
| 2019-08-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $214.53 | $79,805 | 18,010 |
| 2019-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 48,324 |
| 2019-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $216.26 | $1,161,100 | 20,713 |
| 2019-08-09 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2019-08-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 2,600 | $0.00 | $0 | 41,232 |
| 2019-08-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 27,900 |
| 2019-08-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $211.54 | $983,661 | 32,248 |
| 2019-08-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-08-01 | VON SCHACK WESLEY W | Dir |
Open-market sell
S
|
Common Stock | 2,000 | $217.27 | $434,532 | 8,000 |
| 2019-08-01 | VON SCHACK WESLEY W | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $217.27 | $217,266 | 29,743 |
| 2019-07-29 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 21,000 | $0.00 | $0 | 62,800 |
| 2019-07-29 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 12,730 | $211.50 | $2,692,363 | 20,713 |
| 2019-07-29 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 8,270 | $212.56 | $1,757,898 | 33,443 |
| 2019-07-29 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 21,000 | $41.94 | $880,740 | 41,713 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 7,297 | $211.57 | $1,543,837 | 0 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 10,120 | $211.57 | $2,141,104 | 0 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 4,992 | $211.41 | $1,055,357 | 13,535 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 4,800 | $212.30 | $1,019,037 | 18,527 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 4,625 | $209.99 | $971,184 | 23,327 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 3,000 | $213.12 | $639,362 | 27,952 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 7,297 | $35.78 | $261,123 | 30,952 |
| 2019-07-25 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 10,120 | $41.94 | $424,433 | 23,655 |
| 2019-07-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 328 | $191.70 | $62,878 | 662 |
| 2019-07-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 780 | $191.70 | $149,526 | 18,382 |
| 2019-07-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $191.70 | $71,312 | 19,162 |
| 2019-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 53,693 |
| 2019-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $190.09 | $1,020,593 | 20,713 |
| 2019-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,082 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 328,500 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 20,000 | $0.00 | $0 | 765,400 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 11,200 | $189.44 | $2,121,703 | 82,920 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,600 | $188.28 | $1,430,935 | 94,120 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,050 | $189.93 | $769,218 | 101,720 |
| 2019-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 105,770 |
| 2019-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 32,550 |
| 2019-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $186.17 | $865,690 | 32,248 |
| 2019-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,898 |
| 2019-07-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 33,588 |
| 2019-07-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $186.95 | $1,255,533 | 117,429 |
| 2019-07-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 124,145 |
| 2019-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 59,062 |
| 2019-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $184.55 | $990,849 | 20,674 |
| 2019-06-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,043 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,850 | $0.00 | $0 | 361,350 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 11,629 | $184.65 | $2,147,245 | 72,920 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,321 | $183.82 | $1,529,591 | 84,549 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,900 | $182.85 | $347,423 | 92,870 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,000 | $186.41 | $186,410 | 94,770 |
| 2019-06-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,850 | $35.78 | $1,175,537 | 95,770 |
| 2019-06-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 37,200 |
| 2019-06-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $175.50 | $816,075 | 32,173 |
| 2019-06-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 36,823 |
| 2019-06-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 40,304 |
| 2019-06-03 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $169.75 | $1,140,041 | 117,386 |
| 2019-06-03 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 124,102 |
| 2019-05-30 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 3,000 | $169.60 | $508,790 | 43,832 |
| 2019-05-17 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,369 | $0.00 | $0 | 64,431 |
| 2019-05-17 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,369 | $175.06 | $939,897 | 20,674 |
| 2019-05-17 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,369 | $35.78 | $192,130 | 26,043 |
| 2019-05-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 328 | $177.92 | $58,358 | 1,318 |
| 2019-05-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 774 | $177.92 | $137,710 | 20,622 |
| 2019-05-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $177.92 | $66,186 | 21,396 |
| 2019-05-14 | Wood Larry L | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 1,066 | $178.17 | $189,929 | 117,386 |
| 2019-05-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Performance Rights | 2,689 | $0.00 | $0 | 0 |
| 2019-05-12 | Wood Larry L | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 1,334 | $181.10 | $241,587 | 118,452 |
| 2019-05-12 | Wood Larry L | CVP, TAVR |
Other disposed transaction
F
|
Common Stock | 707 | $181.10 | $128,038 | 119,786 |
| 2019-05-12 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 2,689 | $0.00 | $0 | 120,493 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,800 | $0.00 | $0 | 394,200 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,118 | $179.73 | $1,459,077 | 51,801 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 7,780 | $180.52 | $1,404,477 | 59,919 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,152 | $176.77 | $1,087,461 | 67,699 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,338 | $178.75 | $954,185 | 73,851 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,175 | $177.53 | $741,199 | 79,189 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,237 | $181.41 | $224,405 | 83,364 |
| 2019-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,800 | $35.78 | $1,173,748 | 84,601 |
| 2019-05-09 | VON SCHACK WESLEY W | Dir |
Equity grant / award
A
|
Common Stock | 414 | $0.00 | $0 | 1,737 |
| 2019-05-09 | VON SCHACK WESLEY W | Dir |
Equity grant / award
A
|
Common Stock | 1,323 | $0.00 | $0 | 1,323 |
| 2019-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
A · derivative
|
Performance Rights | 10,825 | $0.00 | $0 | 10,825 |
| 2019-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
A · derivative
|
Employee Stock Option (Right to Acquire) | 85,600 | $0.00 | $0 | 85,600 |
| 2019-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
A
|
Common Stock | 8,675 | $0.00 | $0 | 51,801 |
| 2019-05-06 | WANG HUIMIN | CVP, Japan & International |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 41,850 |
| 2019-05-06 | WANG HUIMIN | CVP, Japan & International |
Open-market sell
S
|
Common Stock | 4,650 | $176.17 | $819,190 | 31,321 |
| 2019-05-06 | WANG HUIMIN | CVP, Japan & International |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 35,971 |
| 2019-05-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 47,020 |
| 2019-05-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $176.34 | $1,184,299 | 115,779 |
| 2019-05-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 122,495 |
| 2019-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,800 | $0.00 | $0 | 427,000 |
| 2019-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,975 | $174.79 | $2,966,997 | 43,126 |
| 2019-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,425 | $174.17 | $1,815,675 | 60,101 |
| 2019-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,400 | $175.67 | $948,619 | 70,526 |
| 2019-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,800 | $35.78 | $1,173,748 | 75,926 |
| 2019-04-26 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 821 | $0.00 | $0 | 0 |
| 2019-04-26 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 821 | $175.36 | $143,971 | 13,355 |
| 2019-04-26 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 821 | $42.73 | $35,077 | 14,176 |
| 2019-04-18 | Edwards Lifesciences Holding, Inc. | 10% |
Other acquired transaction
J
|
Common Stock, $0.004 par value per share | 40,049,789 | — | — | 40,049,789 |
| 2019-04-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 328 | $192.00 | $62,976 | 1,646 |
| 2019-04-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 774 | $192.00 | $148,608 | 20,358 |
| 2019-04-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $192.00 | $71,424 | 21,132 |
| 2019-04-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 300 | $0.00 | $0 | 300 |
| 2019-04-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 300 | $189.95 | $56,985 | 19,115 |
| 2019-04-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 300 | $42.73 | $12,818 | 19,415 |
| 2019-04-09 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,186 | $0.00 | $0 | 4,188 |
| 2019-04-09 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 4,186 | $188.23 | $787,931 | 40,410 |
| 2019-04-09 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 4,186 | $42.73 | $178,847 | 44,596 |
| 2019-04-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,650 | $0.00 | $0 | 46,500 |
| 2019-04-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,650 | $189.31 | $880,292 | 31,321 |
| 2019-04-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,650 | $35.78 | $166,400 | 35,971 |
| 2019-04-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 53,736 |
| 2019-04-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $192.34 | $1,291,745 | 115,779 |
| 2019-04-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 122,495 |
| 2019-03-25 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,186 | $0.00 | $0 | 8,374 |
| 2019-03-25 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Open-market sell
S
|
Common Stock | 4,186 | $188.60 | $789,480 | 40,410 |
| 2019-03-25 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer |
Exercise / conversion
M
|
Common Stock | 4,186 | $42.73 | $178,847 | 44,596 |
| 2019-03-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 328 | $179.10 | $58,745 | 1,974 |
| 2019-03-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 774 | $179.10 | $138,623 | 21,455 |
| 2019-03-15 | Szyman Catherine M. | CVP, Critical Care |
Open-market sell
S
|
Common Stock | 372 | $179.10 | $66,625 | 22,229 |
| 2019-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 600 |
| 2019-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $175.73 | $966,515 | 18,982 |
| 2019-03-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 24,482 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 8,800 | $0.00 | $0 | 459,800 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 24,000 | $0.00 | $0 | 0 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 20,261 | $168.03 | $3,404,355 | 43,126 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 9,095 | $167.24 | $1,521,090 | 63,387 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,444 | $168.80 | $581,337 | 72,482 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 8,800 | $35.78 | $314,908 | 75,926 |
| 2019-03-08 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 24,000 | $42.73 | $1,025,400 | 67,126 |
| 2019-03-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 60,452 |
| 2019-03-01 | Wood Larry L | CVP, TAVR |
Open-market sell
S
|
Common Stock | 6,716 | $170.82 | $1,147,227 | 115,650 |
| 2019-03-01 | Wood Larry L | CVP, TAVR |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 122,366 |
| 2019-02-22 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 500 | $0.00 | $0 | 7,297 |
| 2019-02-22 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 500 | $175.04 | $87,519 | 13,282 |
| 2019-02-22 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 500 | $35.78 | $17,892 | 13,782 |
| 2019-02-21 | Ullem Scott B. | CVP, Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 575 | $0.00 | $0 | 11,376 |
| 2019-02-19 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 2,227 | $177.78 | $395,916 | 23,747 |
| 2019-02-19 | Szyman Catherine M. | CVP, Critical Care |
Other disposed transaction
F
|
Common Stock | 697 | $177.78 | $123,913 | 25,974 |
| 2019-02-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 6,100 |
| 2019-02-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $177.75 | $977,625 | 18,982 |
| 2019-02-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 24,482 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,800 | $0.00 | $0 | 24,000 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,898 | $177.91 | $2,650,485 | 43,126 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,702 | $177.05 | $1,894,770 | 58,024 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,050 | $173.75 | $529,928 | 68,726 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,400 | $175.65 | $421,565 | 71,776 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,750 | $174.65 | $305,646 | 74,176 |
| 2019-02-12 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,800 | $42.73 | $1,401,380 | 75,926 |
| 2019-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,000 | $0.00 | $0 | 0 |
| 2019-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,000 | $171.68 | $686,720 | 31,224 |
| 2019-02-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,000 | $42.73 | $170,900 | 35,224 |
| 2019-02-04 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 67,168 |
| 2019-02-04 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,716 | $169.10 | $1,135,676 | 115,650 |
| 2019-02-04 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 122,366 |
| 2019-01-16 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 11,600 |
| 2019-01-16 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $162.03 | $891,165 | 18,982 |
| 2019-01-16 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 24,482 |
| 2019-01-15 | Szyman Catherine M. | CVP, Critical Care & Vascular |
Open-market sell
S
|
Common Stock | 328 | $155.00 | $50,840 | 2,630 |
| 2019-01-15 | Szyman Catherine M. | CVP, Critical Care & Vascular |
Open-market sell
S
|
Common Stock | 372 | $155.00 | $57,660 | 26,671 |
| 2019-01-07 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,716 | $0.00 | $0 | 73,884 |
| 2019-01-07 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,716 | $148.15 | $994,975 | 115,650 |
| 2019-01-07 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,716 | $41.94 | $281,669 | 122,366 |
| 2019-01-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 4,000 | $0.00 | $0 | 4,000 |
| 2019-01-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 4,000 | $145.33 | $581,320 | 31,224 |
| 2019-01-04 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 4,000 | $42.73 | $170,900 | 35,224 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,800 | $0.00 | $0 | 56,800 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 17,164 | $143.86 | $2,469,251 | 43,126 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 10,036 | $143.04 | $1,435,544 | 60,290 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,600 | $144.91 | $521,679 | 70,326 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $147.34 | $176,808 | 73,926 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 800 | $145.77 | $116,615 | 75,126 |
| 2019-01-03 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,800 | $42.73 | $1,401,380 | 75,926 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,800 | $0.00 | $0 | 89,600 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 14,590 | $145.38 | $2,121,158 | 43,126 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 6,464 | $144.63 | $934,869 | 57,716 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,395 | $147.69 | $649,106 | 64,180 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 3,600 | $146.42 | $527,120 | 68,575 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,841 | $148.44 | $421,730 | 72,175 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 910 | $149.37 | $135,929 | 75,016 |
| 2018-12-21 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,800 | $42.73 | $1,401,380 | 75,926 |
| 2018-12-14 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,300 | $0.00 | $0 | 0 |
| 2018-12-14 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,300 | $162.66 | $1,024,758 | 115,650 |
| 2018-12-14 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,300 | $42.73 | $269,168 | 121,950 |
| 2018-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 17,100 |
| 2018-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $164.99 | $907,445 | 18,982 |
| 2018-12-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 24,482 |
| 2018-12-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,800 | $0.00 | $0 | 8,000 |
| 2018-12-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,800 | $155.87 | $592,306 | 31,224 |
| 2018-12-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,800 | $42.73 | $162,355 | 35,024 |
| 2018-11-29 | VON SCHACK WESLEY W | Dir |
Open-market sell
S
|
Common Stock | 1,319 | $160.96 | $212,302 | 28,609 |
| 2018-11-21 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 2,600 | $0.00 | $0 | 821 |
| 2018-11-21 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 2,600 | $153.18 | $398,273 | 13,282 |
| 2018-11-21 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 2,600 | $42.73 | $111,085 | 15,882 |
| 2018-11-20 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,259 | $0.00 | $0 | 3,421 |
| 2018-11-20 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Open-market sell
S
|
Common Stock | 5,259 | $153.14 | $805,385 | 13,282 |
| 2018-11-20 | SELLERS ROBERT W.A. | VP, Corporate Controller |
Exercise / conversion
M
|
Common Stock | 5,259 | $42.73 | $224,691 | 18,541 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,900 | $0.00 | $0 | 122,400 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 18,760 | $150.18 | $2,817,456 | 43,126 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,340 | $151.19 | $1,260,886 | 61,886 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,200 | $152.06 | $638,641 | 70,226 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,100 | $153.99 | $169,386 | 74,426 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 500 | $155.06 | $77,532 | 75,526 |
| 2018-11-19 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,900 | $42.73 | $1,405,652 | 76,026 |
| 2018-11-15 | Szyman Catherine M. | CVP, Critical Care & Vascular |
Open-market sell
S
|
Common Stock | 328 | $147.96 | $48,531 | 3,286 |
| 2018-11-15 | Szyman Catherine M. | CVP, Critical Care & Vascular |
Open-market sell
S
|
Common Stock | 372 | $147.96 | $55,041 | 27,400 |
| 2018-11-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 22,600 |
| 2018-11-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $149.62 | $822,910 | 19,990 |
| 2018-11-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,490 |
| 2018-11-07 | WANG HUIMIN | CVP, Japan & Intercontinental |
Equity grant / award
G
|
Common Stock | 16,641 | $0.00 | $0 | 31,224 |
| 2018-11-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 15,000 | $149.92 | $2,248,803 | 47,865 |
| 2018-11-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Equity grant / award
G
|
Common Stock | 3,953 | $0.00 | $0 | 46,832 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,800 | $0.00 | $0 | 11,800 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 9,578 | $149.66 | $1,433,459 | 62,865 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,800 | $152.60 | $579,880 | 72,443 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 2,601 | $150.98 | $392,687 | 76,243 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 1,500 | $152.60 | $228,900 | 78,844 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 1,321 | $151.97 | $200,757 | 80,344 |
| 2018-11-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,800 | $42.73 | $162,355 | 81,665 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,900 | $0.00 | $0 | 155,300 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,259 | $141.06 | $1,165,015 | 43,126 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 8,101 | $142.37 | $1,153,339 | 51,385 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 5,705 | $140.33 | $800,583 | 59,486 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 4,797 | $139.22 | $667,828 | 65,191 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,638 | $138.21 | $364,600 | 69,988 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,200 | $142.92 | $314,424 | 72,626 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $137.10 | $164,518 | 74,826 |
| 2018-10-29 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,900 | $42.73 | $1,405,652 | 76,026 |
| 2018-10-15 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,300 | $0.00 | $0 | 12,600 |
| 2018-10-15 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,300 | $142.64 | $898,632 | 115,650 |
| 2018-10-15 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,300 | $42.73 | $269,168 | 121,950 |
| 2018-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 28,100 |
| 2018-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $147.50 | $811,250 | 19,990 |
| 2018-10-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,490 |
| 2018-10-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,800 | $0.00 | $0 | 15,600 |
| 2018-10-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,800 | $152.79 | $580,598 | 77,865 |
| 2018-10-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,800 | $42.73 | $162,355 | 81,665 |
| 2018-09-14 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,300 | $0.00 | $0 | 18,900 |
| 2018-09-14 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,300 | $146.95 | $925,785 | 115,650 |
| 2018-09-14 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,300 | $42.73 | $269,168 | 121,950 |
| 2018-09-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 33,600 |
| 2018-09-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $144.16 | $792,880 | 19,990 |
| 2018-09-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,490 |
| 2018-09-05 | Ullem Scott B. | CVP, CFO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 25,036 | $0.00 | $0 | 0 |
| 2018-09-05 | Ullem Scott B. | CVP, CFO |
Open-market sell
S
|
Common Stock | 20,936 | $139.81 | $2,927,098 | 15,983 |
| 2018-09-05 | Ullem Scott B. | CVP, CFO |
Open-market sell
S
|
Common Stock | 2,300 | $140.76 | $323,748 | 36,919 |
| 2018-09-05 | Ullem Scott B. | CVP, CFO |
Open-market sell
S
|
Common Stock | 1,800 | $141.81 | $255,262 | 39,219 |
| 2018-09-05 | Ullem Scott B. | CVP, CFO |
Exercise / conversion
M
|
Common Stock | 25,036 | $34.05 | $852,476 | 41,019 |
| 2018-08-31 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 75 | $144.24 | $10,818 | 19,990 |
| 2018-08-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 39,100 |
| 2018-08-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $136.73 | $752,015 | 20,065 |
| 2018-08-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,565 |
| 2018-08-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,900 | $0.00 | $0 | 221,100 |
| 2018-08-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 32,300 | $142.35 | $4,598,054 | 43,126 |
| 2018-08-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 500 | $143.04 | $71,521 | 75,426 |
| 2018-08-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 100 | $143.92 | $14,392 | 75,926 |
| 2018-08-07 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,900 | $42.73 | $1,405,652 | 76,026 |
| 2018-08-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,800 | $0.00 | $0 | 23,200 |
| 2018-08-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,800 | $144.99 | $550,962 | 84,683 |
| 2018-08-06 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,800 | $42.73 | $162,355 | 88,483 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 32,900 | $0.00 | $0 | 254,000 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 16,778 | $142.30 | $2,387,531 | 43,126 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 12,807 | $141.61 | $1,813,565 | 59,904 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 2,915 | $140.31 | $408,990 | 72,711 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Open-market sell
S
|
Common Stock | 400 | $143.03 | $57,211 | 75,626 |
| 2018-07-31 | MUSSALLEM MICHAEL A | Chairman & CEO |
Exercise / conversion
M
|
Common Stock | 32,900 | $42.73 | $1,405,652 | 76,026 |
| 2018-07-25 | MUSSALLEM MICHAEL A | Chairman & CEO |
Equity grant / award
G
|
Common Stock | 47,305 | $0.00 | $0 | 745,400 |
| 2018-07-16 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,300 | $0.00 | $0 | 31,500 |
| 2018-07-16 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,300 | $148.02 | $932,526 | 115,650 |
| 2018-07-16 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,300 | $42.73 | $269,168 | 121,950 |
| 2018-07-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 44,600 |
| 2018-07-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $145.57 | $800,635 | 20,065 |
| 2018-07-11 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,565 |
| 2018-07-10 | Wood Larry L | CVP, THV Replacement |
Other disposed transaction
F
|
Common Stock | 564 | $146.99 | $82,902 | 115,650 |
| 2018-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 3,800 | $0.00 | $0 | 27,000 |
| 2018-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Open-market sell
S
|
Common Stock | 3,800 | $146.60 | $557,080 | 84,683 |
| 2018-07-05 | WANG HUIMIN | CVP, Japan & Intercontinental |
Exercise / conversion
M
|
Common Stock | 3,800 | $42.73 | $162,355 | 88,483 |
| 2018-07-03 | Ullem Scott B. | CVP, CFO |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 25,000 | $0.00 | $0 | 50,036 |
| 2018-07-03 | Ullem Scott B. | CVP, CFO |
Open-market sell
S
|
Common Stock | 24,200 | $145.65 | $3,524,803 | 16,265 |
| 2018-07-03 | Ullem Scott B. | CVP, CFO |
Open-market sell
S
|
Common Stock | 800 | $146.29 | $117,034 | 40,465 |
| 2018-07-03 | Ullem Scott B. | CVP, CFO |
Exercise / conversion
M
|
Common Stock | 25,000 | $34.05 | $851,250 | 41,265 |
| 2018-06-15 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 6,300 | $0.00 | $0 | 37,800 |
| 2018-06-15 | Wood Larry L | CVP, THV Replacement |
Open-market sell
S
|
Common Stock | 6,300 | $151.86 | $956,718 | 116,156 |
| 2018-06-15 | Wood Larry L | CVP, THV Replacement |
Exercise / conversion
M
|
Common Stock | 6,300 | $42.73 | $269,168 | 122,456 |
| 2018-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M · derivative
|
Employee Stock Option (Right to Acquire) | 5,500 | $0.00 | $0 | 50,100 |
| 2018-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 4,000 | $153.22 | $612,861 | 50,785 |
| 2018-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Open-market sell
S
|
Common Stock | 5,500 | $150.00 | $825,000 | 20,012 |
| 2018-06-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development |
Exercise / conversion
M
|
Common Stock | 5,500 | $42.73 | $234,988 | 25,512 |